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ABSTRACT
PROBABILITY OF CONCEPTION AFTER FERTILITY COUNSELING AND THE
ASSOCIATION OF SEXUALLY TRANSMITTED INFECTIONS WITH
PREGNANCY IN THE LOUSSI STUDY
Lindsey Adelle Wood
July 24, 2019

This study interrogated predictors of pregnancy and the effect of a history
of sexually transmitted infection (STI) on probability of conception among a
cohort of women seeking fertility counseling (N=170), using multivariable logistic
regression and Cox proportional hazards models. There were 76 (44.7%) total
pregnancies. 32 (39.0%) were achieved spontaneously by women who never
received ART (N=82). Among women who did receive ART (N=88), 35 (39.7%)
were achieved by ART and 9 (10.2%) achieved spontaneously. Among the full
cohort (N=170), obesity was a significant negative predictor of pregnancy while
history of human papilloma virus was a significant negative predictor of time to
pregnancy. Among those who did receive ART (N=88), ovarian infertility
diagnosis was a significant positive predictor of pregnancy, relative to other
infertility diagnoses. History of STI was nonsignificantly associated with
increased probability of pregnancy in all sub-samples, though this result may be
confounded by characteristics like coital frequency.
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A. INTRODUCTION
The clinical definition of infertility is “the failure to achieve a clinical
pregnancy after 12 months or more of regular unprotected sexual intercourse”
[1]. When such a failure occurs, many couples find assisted reproductive therapy
(ART) an attractive option. These therapies include, but are not limited to, in-vitro
fertilization (IVF) and intracytoplasmic sperm injection (ICSI). Some treatments
end successfully, with the patient having an assisted conception and live birth.
However, some treatments are unsuccessful in that they do not produce a
conception. In this case, the patient has the option to continue therapy with more
cycles, or to discontinue treatment for varying reasons, such as the stresses that
can be induced during treatment or the cost of the treatment.
After discontinuation of ART, either successful or otherwise, or even if no
ART was ever received, there is still a possibility that an infertile patient may
have a spontaneous conception, meaning that the patient conceived on their own
while not receiving any form of ART. Varying studies have found spontaneous
conception rates after ART treatment to be anywhere from 17% to 34% [2-8].
These studies, however, vary in their defined population. For example, some
studies [3-6] only include patients that had live births from IVF or ICSI, while
others [7, 8] include successful and unsuccessful treatments from ART, while still
others only include those who had unsuccessful treatment [2] or a specific
infertility diagnosis [9].
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Fertility in women can be affected by the woman’s history of a handful of
STIs [10-19]. Chlamydia, specifically, is the major cause of pelvic inflammatory
disease (PID), which can lead to tubal factor infertility, and can also lead to
adverse pregnancy outcomes such as ectopic pregnancy via PID, premature
rupture of the membrane, preterm birth, low birth weight, and stillbirth [10]. Also,
although it is well known that HPV is the cause of most, if not all, cervical
cancers, chlamydia is thought to play a significant cofactor role in these
developments [10]. Gonorrhea can also lead to PID, although higher proportions
of chlamydia than gonorrhea have been found in women with PID [11]. Likewise,
gonorrhea has been associated with endometriosis diagnosis, although not as
associated as chlamydia [12]. Salpingitis (inflammation of the fallopian tubes)
associated with chlamydia and gonorrhea is causal of tubal infertility [13, 14].
Gonorrhea infection is not as strongly associated with tubal infertility as
chlamydia is [15, 16], and likelihood of conception for any type of infertility is
higher in those with gonorrhea infection than with chlamydia infection [14]. The
effects of HPV on infertility are well-established in males, but little is known about
the effects on infertility in women [17, 18]. It is established, however, that HPV
infection in women can cause adverse pregnancy outcomes, such as miscarriage
and the premature rupture of the membrane [18]. The effects of herpes simplex
virus on male infertility is also well-established, but herpes infection has no
association with cervical factor infertility [19]. Herpes may, however, be
associated with PID, although this is not definitive [20]. For all of these reasons, it
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is somewhat surprising that few studies have included STI history while
conducting conception analyses among infertile couples.
The purpose of this study is to determine the effects of STI history on the
likelihood of achieving pregnancy and on the time to achieve pregnancy among a
cohort of women seeking infertility treatment, whether or not they received ART
treatments. Also, predictive models will be produced in order to determine which
factors predict the likelihood of pregnancy and the time to achieve pregnancy
among the infertile women.
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B. SPECIFIC AIMS AND HYPOTHESES
The primary objective of this study is to analyze numerous factors to
determine their effects on the probability of achieving pregnancy and to assess
which factors predict the time to achieve pregnancy among three sub-samples of
the prospective LOUSSI cohort: 1) the entire prospective cohort of women
seeking fertility care, 2) the women who have ever received ART treatments, and
3) the women who have never received ART treatments.
The specific aims of the study are as follows;
Specific Aim 1: To estimate the effect of STI history on a) the
probability of pregnancy and b) the time to pregnancy. Hypothesis: a history
of STI will be negatively associated with the probability of pregnancy and the time
to pregnancy among all sub-samples.
Specific Aim 2: To identify factors which predict a) the probability of
achieving pregnancy after fertility counseling and b) the time to achieving
pregnancy. Hypothesis: factors that will predict the probability of pregnancy and
the time to pregnancy will be age, obesity, AMH levels, unexplained infertility,
and history of STI.
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C. BACKGROUND AND SIGNIFICANCE

Fertility Care Definitions
There are many terms that should be defined in order to obtain a full
clinical understanding of fertility. In 2017, the World Health Organization (WHO)
and the International Committee for Monitoring Assisted Reproductive
Technologies (ICMART), along with other experts, revised the existing 2009
International Glossary on Infertility and Fertility Care [1]. As a result, The
International Glossary on Infertility and Fertility Care, 2017 is an agreement on
clinical definitions of infertility and other relevant terms [21].
Before being able to fully understand infertility, three important fertility care
definitions need to be distinguished: “fertility,” “fecundity,” and “fecundability.”
“Fertility” is the ability to “establish a clinical pregnancy,” where “clinical
pregnancy” is a “pregnancy diagnosed by ultrasonographic visualization of one or
more gestational sacs.” Conversely, “fecundity” is the “capacity to have a live
birth,” where “live birth” is a birth in which the child is completely extracted from
the mother after 22 weeks of gestation and shows evidence of live. Further,
“fecundability” is the “probability of a pregnancy, during a single menstrual cycle
in a woman with adequate exposure to sperm and no contraception, culminating
in a live birth.” In brief, “fertility” is the ability to achieve pregnancy, “fecundity” is
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the ability to achieve a live birth, and “fecundability” is the probability of achieving
a pregnancy in one menstrual cycle leading to a live birth [21].
Often interchanged, “infertility” and “subfertility” are defined as “the failure
to establish a clinical pregnancy after 12 months of regular, unprotected sexual
intercourse.” This means that any person who has not been preventing
pregnancy, and has frequent coital activity, but has not achieved pregnancy
within a year’s time, is clinically infertile. However, the definition also states that
“fertility interventions may be initiated in less than 1 year based on…age,”
meaning that providers can offer infertility treatments for women 35 years of age
or older after only 6 months of trying and failing to achieve a pregnancy [22].
Additionally, an infertility diagnosis may not be definite; “sterility” is the term used
when infertility becomes a permanent state. Infertility can either be a primary or
secondary diagnosis for either a male or the female partner. One is diagnosed
with “primary infertility” when he/she has never initiated or been diagnosed with a
clinical pregnancy before. Conversely, “secondary infertility” is the state of
infertility in a male whom has successfully initiated a clinical pregnancy or in a
female who has been diagnosed as clinically pregnant.

Epidemiology of Infertility
The prevalence of infertility has proved to be difficult to estimate; the
estimate can be easily affected by how the condition is being defined or
diagnosed. One review paper concluded that based on the literature, it is nearly
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impossible to calculate a prevalence [23]. This is largely due to the inconsistency
in calculating infertility, especially in calculating the denominators; some of which
consist of women attempting conception, women who are currently married,
being ever married, and even all women. However, a 2012 World Health
Organization study used 277 national, regional, and global surveys on infertility to
produce the best estimate of prevalence of infertility [24]. The authors greatly
detailed the definitions of their calculations; in the numerator of primary infertility
prevalence were women whom were part of an infertile couple, while the
denominator was women who were a part of infertile couples and a part of fertile
couples – of which had one successful live birth and have been in the same
relationship for at least five years. Likewise, in the numerator of the prevalence of
secondary infertility were women whom were part of an infertile couple, but the
denominator included women whom were a part of an infertile couple and women
whom were a part of a fertile couple – of which had one successful live birth
within the past five years and were in the same relationship five years after their
first live birth. The authors concluded that the prevalence of primary infertility in
2010 among women seeking to have a child was 2.7%, 2.0%, and 1.6% in age
ranges of 20-24 years, 25-29 years, and 30-44 years, respectively. The overall
primary infertility and secondary infertility prevalence for 2010 was 1.9% and
10.5%, respectively. In 2010, women in the United States of America had a fairly
low prevalence of secondary infertility of under 6%, while some countries in
Eastern Europe and Central Asia had a secondary infertility prevalence of over
16%. It was also estimated that there are 19.2 million and 29.3 million couples

7

with primary and secondary infertility, summing at 48.5 million couples with
infertility, globally.
Within the United States, infertility among women has decreased from
1965 to 2010 [25]. A CDC study reported that 11.2%, 8.5% and 6.0% of married
women ages 15-44 in the United States were infertile in 1965, 1982, and 20062010, respectively. The number of women infertile in 1965, 1982, and 2006-2010
were 2.96 million, 2.39 million, and 1.53 million, respectively. Between 2006 and
2010, estimates of primary infertility among married women ages 15-24, 25-29,
30-34, 35-39, and 40-44 were 7%, 9%, 9%, 25%, and 30%, respectively,
accounting for 700,000 infertile married women. Additionally, 830,000 married
women between the ages of 15 and 44 experience secondary infertility between
2006 and 2010.

Infertility Diagnoses
There are many pathophysiology defects by which infertility can arise. In
the female, defects can occur along any part of the reproductive system,
including the fallopian tubes, the uterus or the endometrium, and the ovaries. In
the male, defects of the sperm can arise through a number of causes. The cause
of infertility in a couple could also be due to unknown causes, by which the cause
of infertility is deemed as unexplained. This section dives into each infertility
diagnosis, and the pathophysiology of each.
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Female: Tubal Factor
In the conception process, the role of the fallopian tubes is to transport the
egg and the sperm, as well as to house a newly fertilized embryo during its first
stages of development [26]. When the fallopian tubes are damaged, female
infertility can occur. Tubal factor infertility refers to the blockage or occlusion of
the fallopian tubes. When this occurs, infertility is potentially caused by 1) sperm
being unable to fertilize the egg, or by 2) a fertilized egg not being able to reach
the uterus to be implanted. Reported prevalence of tubal factor infertility among
infertile couples in 2003 and 2008 ranges from 12% to 33% [26] and 25% to 35%
[27], respectively.
There are several etiologies of tubal factor infertility, but the most common
source is pelvic inflammatory disease (PID). It has been estimated that in the
United States, 8% of women between the ages of 16 and 46 are diagnosed with
PID, and more than 1 million women are treated for PID annually [28]. PID is
strongly associated with tubal factor infertility, and as PID episodes increase, so
does the rate of tubal factor infertility; after one, two, and three episodes, tubal
infertility rates can be up 8%, 19.5%, and 40%, respectively [29]. It should be
noted that PID is mainly caused by chlamydia infection and gonorrhea infection;
however, for the purposes of this thesis, these topics are reviewed in a separate
section.
Other, less common causes of tubal factor infertility are endometriosis,
and surgical complications. Although endometriosis can be considered a female
infertility diagnosis on its own, it can also contribute to development of tubal
9

factor infertility; when pelvic adhesions are present from endometriosis near the
fallopian tubes, it is possible that distortion occurs in the tubes [26]. Finally, prior
abdominal surgeries can cause tubal factor infertility by promoting adhesions
when the epithelial cells of the peritoneum do not regrow correctly [30].

Female: Uterine Factor
Regarding reproduction, the uterus plays an imperative role. The uterus is
where a fertilized egg is implanted, and the uterus remains the home of the
growing fetus until birth. There are several uterine factors that can inflict infertility
on a woman, these include congenital factors, fibroids, intrauterine adhesions,
endometriosis, and other cervical factors.
There are several congenital uterine disorders. These disorders are the
most common genital tract abnormalities in females [28]. The most common
congenital malformation of the uterus, and the most debated, is septate uterus
i.e. uterine septum, a condition characterized by the upper wall of the uterus
protruding into the wall of uterus, thereby creating a divide or septate [31].
Although septate uteri have been reported to be associated with recurrent
pregnancy loss [28, 32], there is insufficient evidence to support the association
between uterine septum and infertility [32, 33].
Uterine leiomyomata, i.e. myomas or fibroids, are benign tumors. Fibroids
occur in 20% - 40% of reproductive-aged women, making them the most
common benign tumors among women of reproductive age [34]. One possible
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symptom of uterine fibroids is infertility; however, uterine fibroids are typically
asymptomatic and infertility is a rare symptom [34]. When infertility does occur
from fibroids, there are several mechanism of occurrence, including but not
limited to obstruction of the fallopian tubes, distorted or inflamed endometrium,
and reduced exposure to sperm as a result of a displaced cervix [35].
Intrauterine adhesions are also known to affect fertility in women, with
estimates of 1.5% of infertile women experiencing them [36]. The most common
symptoms of intrauterine adhesions are menstrual disruptions and infertility [37].
Infertility by intrauterine adhesions is caused through the uterine cavity becoming
partially or completely obliterated from repeated curettage, mainly after abortions
and delayed removal of the placenta after delivery [36]. Endometriosis is defined
by the endometrial tissue being present outside of the endometrium, such as in
the pelvic peritoneum or the ovaries [38]. Endometriosis affects 6-10% of all
females [38] and 5-15% of reproductive-aged women [28], but reaches to 3550% in women with pain or infertility [38]. Symptoms of endometriosis include
chronic pelvic pain, abnormal uterine bleeding, and infertility [28]. Infertility
caused by endometriosis is mainly due to the resulting inflammation, which can
lead to dysfunction in ovulation, sperm phagocytosis, impaired fertilization, and
problems with implantation [39]. Although the origins of endometriosis are widely
unknown, the most accepted theory on the pathogenesis of endometriosis is
Sampson’s theory of retrograde menstruation: during menstruation, endometrial
tissue flows up the fallopian tubes and into the peritoneal cavity [40]. Sampson’s
theory is also supported by his observation of menstrual blood leaving through
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the fallopian tubes and his findings of endometrial tissue in the lumen of some of
his female patients with endometriosis [40]. However, Sampson’ theory has
faced questioning due to the fact that most women have retrograde
menstruation, but only 6-10% of women are diagnosed with endometriosis [38].
There are now a number of theoretical pathogeneses of endometriosis, including
genetic factors, immune factors, and some environmental factors.
The cervix is mainly responsible for keeping a fetus in the uterus until birth
[41]. The mucus produced by the cervix changes during the menstrual cycle, and
the production of abnormal mucus has been thought to inhibit the ability of sperm
to enter the uterus [42]. However, cervical factors are rarely diagnosed as the
main cause of infertility [43, 44]. This is largely due to the fact that the diagnostic
test for cervical factors, the post-coital test, is unreliable and does not predict
infertility [43, 44]. The test is no longer recommended in infertility evaluations
[43].

Female: Ovarian Factor
The primary function of the ovaries is to produce a mature follicle that will
release an egg, in a process called ovulation. Ovarian factor infertility is
diagnosed when a woman does not ovulate, or experiences anovulation. This
ovarian dysfunction accounts for 40% of female infertility [45]. There are several
causes of ovarian factor infertility, and the World Health Organization categorizes
ovulation disorders into three groups [46].
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Group I consists of women who have hypogonadotropic (secondary)
hypogonadism, which is most present in women of low BMI and women who
exercise excessively [47]. These two factors lead to the reduced production of
gonadotrophin releasing hormone by the hypothalamus, which then results in
reduced production of luteinizing hormone (LH) and follicle stimulating hormone
(FSH) by the pituitary gland [47]. The lack of these hormones ultimately leads to
the absence of menstruation, or amenorrhea [47].
Group II includes women of whom have hyperprolactinaemic
amenorrhoea – or hyperprolactinaemia – or polycystic ovarian syndrome
(PCOS). Hyperprolactinaemia results when the pituitary gland produces a
reduced amount of LH and FSH, caused by a microadenoma on the pituitary
gland [47]. The next Group II diagnosis, PCOS, is present in 5-10% of
reproductive aged women [46] and accounts for 70% of infertility due to
anovulation [47]. PCOS arises when the ovary/ovaries produce an excess
amount of androgen, which results in several pre-ovulatory follicles to be formed.
When these follicles don’t respond to FSH, no dominant follicle is produced [47],
and the multiple small follicles remain [46]. PCOS is most common in women in
their late teens to early 20s, and is often present with excessive hair growth
(hirsutism), irregular periods, acne, and obesity [47].
Women in Group III are those women of whom have hypergonadatrophic
(primary) hypogonadism, resulting in ovarian failure or premature menopause.
Primary hypogonadism results from the ovaries not producing enough estrogen
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and producing higher levels of LH and FSH [48]. The resulting premature
menopause makes the patient incapable of ovulating, and therefore, infertile.
Another ovarian factor that can lead to infertility not mentioned in the WHO
classifications is diminished ovarian reserve. Diminished ovarian reserve refers
to a reduced number of and/or reduced quality of oocytes in reproductive aged
women who have regular menstruation [45]. Women with diminished ovarian
reserve generally have lower serum antimüllerian hormone (AMH)
concentrations, which is associated with poor response to ovarian stimulation
and poor IVF pregnancy outcomes [45]. It should be noted however, that an AMH
test with poor results does not imply the inability to conceive [45].

Male Factor Infertility
In reproduction, the role of the male is to have enough sperm ejaculated in
order to fertilize the female’s egg. Male factor infertility is solely responsible for
20% of infertile couples, and contributes to an additional 30-40% of infertile
couples [49]. Most male infertility (90%) is due to poor sperm quality, low sperm
counts, or both [50]. Males with oligozoospermia present semen that consists of
low sperm concentration and low sperm motility. Even more dramatic,
azoospermia is when semen has absolutely no sperm. There are two ways
azoospermia can be caused. Obstructive azoospermia is a result of blockage in
the epididymis or the ejaculatory ducts, therefore preventing sperm to be present
in the semen [51]. Non-obstructive azoospermia is caused by a testicular
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dysfunction, which is the leading cause of disturbed spermatogenesis [51]. Some
cases of non-obstructive azoospermia can include hypergonadotrophic
hypogonadism, which is characterized by higher concentrations of FSH being
present [51]. Conversely, hypogonadotrophic hypogonadism, characterized by
having lower concentrations of FSH and LH, is caused by pituitary or
hypothalamic diseases [51]. When a male presents with normal sperm, infertility
could potentially be caused by ejaculatory problems, such as retrograde
ejaculation and even the lack of ejaculation [49]. Further, there is evidence of
male infertility having a fetal origin, either by genetic mutations leading to sexual
development disorders, or by fetal chemical exposure leading to disruption of
testes development [52].

Unexplained Infertility
The prevalence of unexplained infertility ranges from 8% to 37% [53].
Couples are diagnosed with unexplained infertility when both partners present
with normal fertility evaluations, meaning that there is not one specific
abnormality identified to be causing their infertility. Guidelines do exist on
diagnosing unexplained infertility; the initial evaluation consists of a semen
analysis, ovulation analysis, and evaluations of the uterine cavity and of tubal
patency [43, 44]. When all these evaluations return normal results, unexplained
infertility is diagnosed to the couple. However, unexplained infertility prevalence,
and even the existence of the term itself, remains debated. This is mainly
because the process of diagnosing unexplained infertility, even with said
15

guidelines, is questionable. Firstly, there still remain areas of reproductive
science for which there are no testing procedures, meaning that a true infertility
cause may not currently be possible of being diagnosed [53]. Further, when put
to clinical practice, fertility evaluations vary widely among physicians and are not
consistently executed, potentially leading to misdiagnosis [54]. Unexplained
infertility can be a frustrating diagnosis to couples who are actively trying to
conceive. Unlike the other diagnoses mentioned prior, there is no clear-cut
answer to the problem, and therefore no clear-cut answer on how to approach
treatment.

Treatments for Infertility
With so many causes of infertility, there is not a one-size-fits-all treatment.
Certain infertility diagnoses qualify for some treatments over others. For
example, some diagnoses may only require lifestyle changes to increase the
likelihood of conception, while others may require assisted reproductive
technology (ART). This section explores the varying infertility treatments, how
they work, and which diagnoses are appropriate for each treatment. All
information in this section can be referenced to the National Institute for Health
and Care Excellence (NICE) Clinical Guidelines on infertility treatments [46].

Lifestyle Changes and Expectant Management
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Lifestyle changes are the preferred method of treatment for women of the
Group I ovulation disorders. As mentioned in a prior section, secondary
hypogonadism is present in women with low BMI or who exercise excessively.
For these women, just increasing their BMI, normalizing their exercise, or both
can increase their likelihood of conceiving.
Expectant management is the act of timing sexual intercourse with
ovulation, and of increasing coital activity. Expectant management is the
preferred method of treatment for couples that have an unexplained infertility
diagnosis. It is recommended to these couples to try to conceive for at least 2
years with expectant management. If after 2 years of expectant management,
these couples have still failed to conceive, then the couple is offered IVF
treatment.

Male Factor Treatments
As mentioned prior, there are a number of etiologies for male factor
infertility, of which the main treatment options consist of varying medical and
surgical options, as well as IVF and ICSI, which will be discussed in a later
section. For men with hypogonadotrophic hypogonadism, gonadotrophin drugs
are offered. Men with obstructive azoospermia have the option to consider
surgical repair of the blocked duct, but only as an alternative to sperm recovery
and IVF. Ejaculatory disorders can be treated by a number of options, such as
penile electrovibration and transrectal electroejaculation for anejaculation,
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varying drugs for retrograde ejaculation, and surgical sperm retrieval. IVF/ICSI
are considered when all other treatments fail.

Assisted Reproductive Technologies: Ovulation Induction
Ovulation induction therapy is used for those with ovulatory disorders to
help stimulate the ovaries to produce at least one egg, but usually more than
one. There are several routes to induce ovulation, but they vary by ovulatory
diagnosis. As mentioned prior, there are three groups of ovulation disorders. Of
the three, ovulation induction can only be beneficial for those women in Groups I
and II. For women with hypogonadatrophic hypogonadism (Group I), the first
recommendation is to change their lifestyle factors, such as increasing their
weight and BMI, as well as moderating strenuous exercise. Normalizing these
lifestyle factors can increase their chances of ovulation and even conception.
Doctors also offer these Group I women hormone pills to induce ovulation. For
women with PCOS (Group II), those with a BMI greater than or equal to 30 are
advised to lose weight, as lowering their BMI could restore their ovulation. For
those without a severe BMI, it is recommended that hormone pills be offered,
including an anti-oestrogen (clomiphene citrate), an insulin sensitizer (metformin
hydrochloride), or a combination of both. Those women who do receive
clomiphene citrate and/or metformin hydrochloride should not take the oral
medication for longer than six months.
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Assisted Reproductive Treatments: Intrauterine Insemination
Intrauterine insemination (IUI) consists of inserting sperm directly into the
uterine cavity around the time of ovulation. This treatment can be performed with
or without ovulation induction. When ovulation induction is used, the insemination
process does not occur until after the induction has occurred. Women take
hormone tablets for several days. Then, if during an ultrasound, there is at least
one, but no more than three developed follicles, induction occurs. Insemination
then occurs within the next day to 36 hours.
In the past, IUI has been a treatment for the infertility diagnoses of mild
endometriosis, mild male factor infertility, and unexplained infertility. However,
the most recent NICE guidelines now recommend the following: 1) IUI with no
ovulation induction should be given to those of whom cannot have vaginal
intercourse, such as those with psychosexual disorders, same-sex couples, and
those with conditions of which require special consideration (HIV positive males);
2) for those who have yet to conceive after 6 cycles of IUI, another 6 cycles of IUI
without ovulation induction should be offered before offering IVF; and 3) for those
with diagnoses of mild endometriosis, mild male factor infertility, and unexplained
infertility, IUI should not be offered, but rather continue to attempt to conceive for
at least two years before considering IVF.

Assisted Reproductive Treatments: In Vitro Fertilization and Intracytoplasmic
Sperm Injection
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In Vitro Fertilization is an ART procedure that consists of the fertilization of
eggs with sperm outside of the body. There are seven total stages of IVF, of
which some are not always used. In general, the process consists of stimulating
the female’s ovulation, an ovulation trigger, egg and sperm retrieval, and embryo
replacement. Stimulating ovulation results in eggs being produced, while
ovulation trigger results in the initiation of ovulation. The eggs and sperm are
then retrieved, and fertilization takes place in the laboratory. A few days after
fertilization, the now embryos are placed in the female’s uterus. Patients are
sometimes offered hormones before ovulation stimulation and after embryo
replacement to help with the preparation of the IVF process and with the early
development of the embryo. In general, IVF acts as the last resort treatment
option, only being used when the preferred treatment option for a diagnosis has
failed. IVF is offered to patients of whom the following preferred methods have
failed: 1) expectant management for unexplained diagnoses, 2) ovulation
induction for ovarian disorders, 3) treatment of endometriosis, 4) treatment for
tubal disease, and 5) treatment for identified male factor infertility. The infertility
diagnoses that most warrant IVF, and of which IVF is the preferred treatment, are
those of severe tubal disease and severe male factor.
Intracytoplasmic Sperm Injection is often used in tandem with IVF. ICSI
involves the insertion of a single sperm into an egg during a typical IVF process.
The benefit comes in selecting the specific sperm, usually the best individual
sperm, that will fertilize the egg. For this reason, ICSI is mainly used when
severe male infertility is involved, as the likelihood of fertilization in vitro is still
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very low. These disorders include low sperm quality and obstructive and nonobstructive azoospermia. ICSI is also an option for couples of other diagnoses of
whom regular IVF has failed. However, ICSI with IVF only increases the
likelihood of fertilization, and does not increase the overall conception rate any
better than IVF alone.

Infertility and Spontaneous Conception
Couples who have infertility diagnoses can still sometimes conceive
naturally, regardless of whether they have received ART. Among the literature of
infertile couples, varying studies have found spontaneous conception rates to be
anywhere from 11.2% to 80% [55, 56]. These rates, however, are sometimes
crude rates, while other times are ongoing or cumulative rates. Also, studies vary
highly in their defined population. For example, some studies only include
patients that had prior live births from IVF or ICSI, while others include successful
and unsuccessful treatments from ART, while still others only include those who
had unsuccessful treatment or those of whom remain untreated. Spontaneous
conception and live birth rates by study population are shown in Table 1. It is
difficult to interpret these conception rates relative to the general infertile
population, as each rate is very specific in its rate type and in its population.
Further, some studies only report live birth rates; however, these rates can be
thought of as the minimum conception rate, as there have to be at least as many
conceptions as there are live birth.
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Table 1: Spontaneous Conception and Live Birth Rates Among Infertile Couples
Population
currently receiving ART
currently receiving ART with
unexplained infertility

prior successful ART
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prior unsuccessful ART

untreated by ART

Authors
Vardon et al.

Year
1995

Pinborg et al.

2009

Brandes et al.

2011

Shimizu et al.

1999

Hennelly et al.

2000

Kupka et al.

2003

Ludwig et al.

2008

Troude et al.

2012

Lande et al.

2012

Marcus et al.

2016

Osmanagaoglu et al.

2002

Kupka et al.

2003

Troude et al.

2012

Marcus et al.

2016

Collins et al.

1995

Snick et al.
Eijkemans et al.

1997
2008

Outcome
spontaneous conception
first live birth from
spontaneous conception

Rate
11.2%

N
594

18.2%

817

spontaneous conception

60.2%

437

18.0%

142

20.7%

513

80.0%

32

20.0%

695

17.0%

1320

21.6%

102

27.3%

307

11.5%

200

47.0%

194

24.0%

814

35.4%

96

38.2%

2198

72.0%
9.1%

342
1034

subsequent spontaneous
conception
subsequent spontaneous
conception
subsequent spontaneous
conception
subsequent spontaneous
conception
subsequent live birth from
spontaneous conception
subsequent live birth from
spontaneous conception
subsequent spontaneous
conception
live births from spontaneous
conception
spontaneous conception
live births from spontaneous
conception
subsequent spontaneous
conception
live births from spontaneous
conception
spontaneous conception
spontaneous conception

There are few studies in which the study population consists of infertile couples
who remain untreated by ART. However, spontaneous conceptions rates among
untreated women are relevant to this study, as 82 (48.2%) of the LOUSSI study
population used in this thesis never received any form of ART. Of the three
studies of conception rates among untreated couples, two utilized Cox
proportional hazards models. Resulting cumulative live birth rates were 38.2% at
36 months [57] and 72.0% at 36 months [58]. The median time to conceptions
resulting in live births were 10.4 months and 8.1 months, respectively. The
remaining study utilized a Kaplan-Meier method to determine a one-year
cumulative pregnancy rate at 9.1% [59]. This would be equivalent to a 24.9%
pregnancy rate after 36 months, assuming 9.1% rate per year. At first glance,
these cumulative rates seem drastically different; however, cumulative pregnancy
rates increase with time, so it does make sense that the shorter follow up will
have the lowest cumulative rate.
The number of studies that assess spontaneous conception rates among
infertile women who are actively, but inconsistently receiving ART is also limited.
Among the three identified, one study found a 60.2% spontaneous conception
rate in 5 years among women with unexplained infertility and currently receiving
ART [9]. Conversely, a separate 5-year prospective cohort study found the live
birth rate following spontaneous conceptions to be 20.7% [60]. However, these
births belonged to only 18.2% of the women in the study, meaning that some
women spontaneously conceived and delivered twice within 5 years of initiating
ART. An even more dramatically lower rate is found in a study that is written in a
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language other than English, but the abstract reports that this retrospective study
found that 11.2% achieved a spontaneous conception among women in an IVF
program [55]. However, the follow-up time is unknown. The 5-year spontaneous
conception rates of these studies vary from 18.2% to 60.2%. However, the
highest conception rate was among women with an unexplained infertility
diagnosis, which, as will be shown in a later section, is a diagnosis that usually
results in the highest likelihood of conception.
Most literature regarding conceptions among infertile populations is
conducted among those with prior successful ART treatment. Crude rates are
most often reported, however, and the follow-up times vary in each study. For
example, in one study with a two-year follow-up of women who had prior
successful IVF/ICSI, 20.7% had a subsequent spontaneous conception [3].
Another study, which included 7 to 9 years of follow up time, reported a
cumulative live birth rate of 17% after a prior successful IVF/ICSI [8]. Further, an
internet survey study included varying times of follow up and reported 27.3%
spontaneous conception rate after successful IVF/ICSI [7]. This particular study,
however, may be an overestimation of the true rate, as those women who did
conceive are conceivably more likely to respond to the online survey. Other
studies, with follow-up times between the aforementioned 2 and 9 years, report
spontaneous conception or live birth rates after a successful IVF/ICSI treatment
at 14.2% [56], 18% [6], 20% [4], and 21.6% [5]. The literature on subsequent
spontaneous conceptions after a successful IVF/ICSI treatment show rates
between 14.2% and 27%, with varying follow up times. When mentioned, the
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majority of spontaneous conceptions in all of these studies occurred within the
first two years of follow up; this means that after having a successful IVF/ICSI,
those who will achieve a subsequent spontaneous conception will most likely do
so within the next two years.
Few studies can be identified that assess spontaneous conception rates
after failed ART treatments. The internet study mentioned previously also
analyzed spontaneous conceptions among women who had unsuccessful
IVF/ICSI treatments and decided to discontinue treatments [7]. The authors
report that 35.4% of these women achieved spontaneous conception. Another
study included only women who were younger than 37 years, and reported a live
birth (resulting from spontaneous conception) rate of 11.5% after discontinuing
failed ICSI treatments [61]. Other studies have reported a 14.2% [56]
spontaneous conception rate among those who discontinued IUI or IVF
treatments, and a 24% [8] spontaneous conception rate after discontinuing
unsuccessful IVF treatments. Although these studies reported on the same
general population, spontaneous conception rates varied widely from 11.5% to
35.4%. It should be noted, however, that the largest rate is reported in the
internet survey study, which could potentially be an overestimation of the true
spontaneous conception rate, as those women who did conceive would be more
likely to respond than those who did not conceive.

Predictors of Fertility
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There are a number of factors that are associated with overall fertility and
the likelihood of conception. Accounting for these factors is imperative for
comparing likelihoods of pregnancy across infertile groups. The purpose of this
section is to review the literature on several important predictors of fertility that
should be considered for inclusion in conception models.

Obesity
Overweight, or pre-obesity is defined by the CDC and the WHO as having
a BMI between 25.0 to 29.9, whereas obesity is defined as a BMI of 30.0 or
greater [62, 63]. In the United States, roughly 32% of women (ages 20 to 39
years) are obese. For reproductive-aged women, obesity can have major impacts
on their fertility, including problems with ovulation, fertilization, and uterine
problems.
One of the proposed mechanisms on how obesity can affect ovulation is
through insulin resistance; having insulin resistance can lower the amount of sex
hormone-binding globulins produced in the liver, resulting in increased amounts
of free androgens and free estrogens. This increase of free estrogens ultimately
leads to an increase of FSH released from the pituitary gland, which causes
impaired ovulation [64]. It has also been shown that women who have irregular
menses are four times more likely to be obese than women who have regular
menses [65]. There also seems to be a dose-dependent relationship between the
percentage of anovulatory cycles a woman has and her BMI; for women less
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than 20% overweight, 20-49% overweight, 50-74% overweight, and more than
74% overweight, the percent of anovulatory was 2.6, 4.0, 5.8, and 8.4,
respectively [65]. The insulin resistance associated with obesity is also a main
factor in the development of PCOS; as mentioned prior, PCOS is caused by
excess androgen, leading to multiple follicles to be formed on the ovaries [47].
Further, one study found that women with PCOS were nearly twice as likely to be
overweight than those women without PCOS, with rates of BMIs of 25 or more at
60.6% and 34.8% (p-value < 0.001), respectively [66].
Fertilization can also be a problem for obese women. One study found
that among IVF recipients, women with a BMI between 35 and 39.9, and women
with a BMI of 40 or higher, had significantly fewer normally fertilized oocytes
(mean of 7.7 and 7.6, respectively), compared to the referent group women of
BMI of 18.5 to 24.9 (mean of 9.3) (p-value < 0.03) [67]. The study also showed
that when compared to women with a BMI between 18.5 and 24.9, women with
BMIs between 30 and 34.9, between 35 and 39.9, and 40 or greater had
significantly lower odds of achieving conception on their first IVF cycle, with ORs
of 0.67 (95% CI: 0.46 – 0.97), 0.56 (95% CI: 0.34 – 0.93) and 0.50 (95% CI: 0.31
– 0.82), respectively [67]. There was also a clear dose-dependent relationship
between odds of conception during the first IVF cycle and BMI, suggesting that
an increasing BMI decreases the likelihood of fertilization.
Being obese can also have detrimental effects on the functioning of the
uterus. One study found that among women receiving healthy donor eggs, a
negative linear trend was found between implantation rates and higher BMI (p-
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value = 0.008) [68]. Likewise, when comparing women with a BMI of 25 or
greater with women of a BMI of less than 25, those who were overweight had
significantly lower odds of conceiving, with pregnancy rates of 38.3% and 45.5%,
respectively (p-value = 0.002), and an OR of 0.85 (95% CI: 0.76–0.95) [68].
Obesity can also affect the effectiveness of ART treatments. For instance,
one study found that among women receiving ovulation induction, there was a
significant correlation between weight and the needed dose for conception to
occur (p-value < 0.001) [69]. For women receiving IVF treatments, BMI has been
shown to significantly decrease the odds of conception, with an OR of 0.843
(95% CI: 0.73 – 0.97) for a one-unit increase of BMI [70]. Likewise, a metaanalysis found that when comparing women with a BMI of 25 or greater to
women with a BMI of less than 25, those who were overweight had significantly
lower odds achieving pregnancy (OR = 0.71, 95% CI: 0.62 – 0.81) [71].
Based on the evidence, it is clear that obesity negatively affects all
aspects of fertility, including the efficacy of ART treatments. Lower BMI, at or
below the normal range, can greatly increase the likelihood of both spontaneous
and ART-related conception by resulting in healthy functioning reproductive
organs and normal hormone levels.

Smoking
Cigarette smoking is well-known to be associated with a number of
diseases, including infertility. However, 20.7% of reproductive aged women in the
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United States are smokers [72]. One meta-analysis found that women who were
smokers had higher odds of experiencing infertility than those women who were
not smokers (OR = 1.60, 95% CI: 1.34 – 1.91) [73]. Smoking has the ability to
affect all facets of fertility, including ovarian and fallopian tube function,
fertilization, embryo development, implantation, and even miscarriage [74, 75]. It
has been shown that when comparing age-matched smokers to non-smokers,
ovarian reserve is significantly lower in the smokers (p-value < 0.05), with an
increased OR for diminished ovarian reserve of 2.8 (95% CI: 1.2 – 7.99) [76].
Smoking is also detrimental to fallopian tube functioning, causing a reduced
blood flow [74] and an impaired ability to transfer oocytes [74, 75]. One study
found that women who smoke more than 20 cigarettes per day had four times the
odds of ectopic pregnancies, compared to women who had never smoked (OR=
3.9, 95% CI: 2.6 – 5.9), concluding that transfer of oocytes to the uterus by the
fallopian tubes is reduced due to cigarette smoking [77]. Implantation is also
impaired as a result of smoking; in one study comparing light smokers (0 – 10
cigarettes per day) to heavy smokers (11 – 20 cigarettes per day) using donor
oocytes, the light smokers had a significantly higher pregnancy rate than the
heavy smokers, with pregnancy rates of 52.2% and 34.1%, respectively (p-value
= 0.02) [78]. The results from this study showed that when using a healthy donor
oocyte, implantation is higher among light smokers than heavy smokers.
Cigarette smoking can have a detrimental effect on conception success
while receiving ART treatments. Two meta-analyses found associations between
smoking and lowered ART conception rates. The first found that smokers had
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33% lower odds of conceiving per IVF cycle than non-smokers (OR = 0.66, 95%
CI: 0.49 – 0.88) [73]. The second found that non-smokers had 79% higher odds
of conceiving during the first IVF attempt than smokers (OR = 1.79, 95% CI: 1.24
– 2.59) [78]. Finally, another study showed via multivariable analysis, that women
who have ever smoked had a higher risk of unsuccessful IVF (RR = 2.71, 95%
CI: 1.37 – 5.25) [79]. This study also showed a dose-response to smoking, as
each additional year of smoking increased the risk of having no pregnancy by 9%
(RR = 1.09, 95% CI: 1.0 – 1.16) [79].
Based on the current evidence of smoking and infertility, it is clear that
cigarette smoking is harmful to fertility through more than one pathway.

Ovarian Reserve – Follicle Stimulating Hormone and AntiMüllerian Hormone
Levels
Ovarian reserve refers to a woman’s potential to reproduce, as related to
how many oocytes and the quality of the oocytes she contains [80]. Diminished
ovarian reserve (DOR) refers to reproductive aged women of whom, when
compared to other women of the same age, have lower ovarian stimulation and
fecundity [80]. Follicle stimulating hormone (FSH) and antimüllerian hormone
(AMH) are two measures that are often used to estimate ovarian reserve.
FSH levels vary throughout the menstrual cycle, and testing should occur
between the first and fifth day; during this time, normal FSH levels are below 10
mIU/mL [81]. However, increased FSH levels during this time indicate DOR [80].

30

In one longitudinal cohort study, 437 couples with unexplained infertility were
followed between two and eight years, while observing for any pregnancy [9]. Of
the 437 couples, only 81 couples did not conceive. When comparing those
couples who did conceive against those couples who did not conceive, female
FSH levels were significantly lower in those who did conceive (p-value = 0.02).
However, in a study of older women of reproductive age (30 – 44 years), those
with high serum and urinary FSH levels did not result in a significantly different
pregnancy prediction after 6 cycles of attempt or after 12 cycles of attempt [82].
The contradicting results of whether FSH levels can predict pregnancy chances
most likely comes from the efficacy of the FSH test, which is known to have a
high specificity, but a low sensitivity [80]. However, the test is still used, as it has
a high positive predictive value, regardless of its simultaneous low negative
predictive value [80].
Levels of AMH vary throughout a woman’s lifetime; levels rise in younger
years, and typically peak around age 25, after which, levels decline until
becoming virtually zero a few years before menopause [80]. AMH is independent
of the menstrual cycle and can therefore be tested at any day of the cycle [80].
Depending on the woman’s age, normal AMH levels range between 0.5 ng/mL
and 2.7 ng/mL [81]. Lowered AMH levels are clinically indicative of DOR. In one
study of women receiving IVF/ICSI treatments, women who achieved live births
as a result of treatment had significantly higher AMH levels than those women
who did not achieve live births (p-value = 0.001) [83]. Likewise, in women
receiving IUI treatments, those who achieved pregnancy had significantly higher
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AMH levels than those women who did not achieve pregnancy (p-value = P =
0.0004) [84]. Clinically, AMH testing is the most relied-upon ovarian reserve
testing, as it is the most sensitive and is capable of predicting ovarian response
during ART treatments [80].

Sexually Transmitted Infections
STIs such as Chlamydia trachomatis (chlamydia) and Neisseria
gonorrhoeae (gonorrhea) can contribute to reduced fertility in women. It is
surprising, then, that to the best of my knowledge, no studies assessing
characteristics associated with conception among infertile populations include
STI history in their models. The STIs reviewed here are the only STIs reported in
the medical histories of the participants of the current thesis.

Chlamydia trachomatis
The mechanism behind the association between Chlamydia trachomatis
(chlamydia) and infertility is through pelvic inflammatory disease (PID). PID is an
infection of the uterus, fallopian tubes, and pelvic structures, usually caused by
surgery or pregnancy [10]. However, chlamydia is the major cause of PID that is
not associated with pregnancy nor surgery [10], and is responsible for 50% of all
PID cases [85]. PID increases the risk of tubal infertility; with one episode of PID,
the relative risk of tubal infertility is roughly 10%, and each repeat PID episode
nearly doubles the risk of tubal infertility [86, 87]. For example, women with two
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PID episodes have a 20% higher relative risk of tubal disease, and nearly a 40%
higher relative risk after the third episode. Further, another study found
associations between chlamydia antibodies and tubal factor infertility [88].
Another study found that among reproductive-aged women, those with chlamydia
infection had significantly increased odds of infertility, nearly 10 times as high as
those with no chlamydia infection (OR = 9.985, 95% CI: 4.70 – 20.63) [11].
Likewise, it has also been shown that chlamydia antibodies are more frequent in
women with infertility and tubal damage than in women with infertility and no
tubal damage (p-value < 0.0001) [16].

Neisseria gonorrhoeae
Similar to chlamydia, Neisseria gonorrhoeae (gonorrhea) can also cause
PID [12]. However, gonorrhea is much less common in women with PID than is
chlamydia [12], with only 10-19% of PID cases being attributed to gonorrhea
infection [85]. Although gonorrhea infection can also lead to the same tubal factor
infertility, tubal factor infertility is much more of a risk among those infected with
chlamydia. One study found no significant difference of gonorrhea infection
between women with infertility and tubal damage, and women with infertility and
no tubal damage [16]. Similarly, another study found that women with gonorrheaassociated PID were much less likely to experience adverse fertility outcomes
than those with chlamydia-associated PID [14].
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Human Papilloma Virus and Herpes Simplex Virus
Though effects of HPV on infertility are well-established in males, there is
little evidence demonstrating any effect of Human Papilloma Virus (HPV) and of
Herpes Simplex Virus (HSV) on infertility in women [17, 18]. It is established,
however, that HPV infection in pregnant women can cause adverse pregnancy
outcomes, such as miscarriage and the premature rupture of the membrane [18].
Similarly, the effect of HSV on male infertility is also well-established; however,
HSV infection has no association with cervical factor infertility [19]. HSV may,
however, be associated with PID, although this is not definitive [20].

Caffeine
Studies assessing the effects of caffeine on pregnancy have varying
results, keeping the association between the two in current debate. Most studies
of women receiving ART treatments show no association between caffeine and
the likelihood of conception. One study found no linear trend between current
caffeine consumption and pregnancy among women receiving IVF treatments (pvalue for trend = 0.74) [89]. Two more studies report similar findings, with no
association between current caffeine consumption and pregnancy among ART
recipients [90], nor between caffeine consumption the year prior to treatments
and pregnancy among ART recipients [91], even with the median caffeine
consumption of 456 mg per day and 125 mg per day, respectively. Although
studies among women receiving ART treatments report consistent findings,
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studies conducted among women not receiving ART treatments seem to report
findings that are rather inconsistent. One study found that an increased number
of cups of coffee per day (p-value for trend = 0.003), as well as an increased
amount of caffeine per day (p-value for trend = 0.001), had significant negative
trends with increased time to pregnancy [92]. The study also found that women
who consumed more than 500 mg per day of caffeine were 1.45 times the odds
(95% CI: 1.03 – 2.04) to take at least 9.5 months to conceive than women who
drank 100 mg per day or less of caffeine [92]. However, another study conducted
among women not receiving ART treatments found that, for increased caffeine
consumption and achieving conception, the adjusted ORs suggested a general
negative trend with increasing caffeine consumption; however, none of the ORs
were significant, and therefore, there was no significant association between
increased caffeine consumption and pregnancy [93].
The majority of evidence suggests that caffeine consumption has little to
no effect on the likelihood of pregnancy. However, even with very few studies
reporting associations, the association between caffeine and pregnancy cannot
be entirely ruled out, but it should be noted that caffeine may be a proxy measure
for other behaviors or dietary factors and residual confounding is likely a problem
in most studies.

Alcohol
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The effects of alcohol on pregnancy remain in question, as varying studies
report conflicting results. Some report that there is a negative association
between how much one drinks and her likelihood of pregnancy, while others
report that there is no association.
In a case-control study of 20 to 40 year old women, no significant linear
trend between increased number of drinks consumed per week and trouble
achieving pregnancy was found [94]. There was also no association with
pregnancy when separate drinks were analyzed; when compared to having no
drinks per week, the ORs for having more than 5 drinks of wine, beer, and spirits
was 1.16 (95% CI: 0.72 – 1.88), 1.06 (95% CI: 0.82 – 1.37), and 1.44 (95% CI:
0.84 – 1.64), respectively.
However, a longitudinal study of reproductive aged women did find
significant associations between alcohol and conception when assessing the
women who were non-smokers [93]. Women who drank 1 to 12 grams, 13 – 90
grams, and greater than 90 grams of alcohol per week had less odds of
conceiving than women who did not drink at all, with ORs of 0.43 (95% CI: 0.25 –
0.76), 0.40 (95% CI: 0.21 – 0.77), and 0.28 (95% CI: 0.20 – 2.15), respectively.
Although the group of women who drank more than 90 grams of alcohol per
week did not result in a significant result due to a small sample size within this
group, the results do show a negative dose response relationship between how
much a woman drinks and her likelihood of pregnancy.
Further, one study found significant associations between amount of
alcohol consumed through the week and infertility diagnoses [95]. Moderate
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drinkers (100 grams or less) and heavy drinkers (more than 100 grams) had
higher odds of having an ovulatory factor infertility diagnosis than nondrinkers,
with ORs of 1.3 (95% CI: 1.0 – 1.7) and 1.6 (95% CI: 1.1 – 2.3), respectively.
Similarly, moderate (OR = 1.6, 95% CI: 1.1 – 2.3) and heavy drinkers (OR = 1.5,
95% CI 0.8 – 2.7) had higher odds of having endometriosis as their infertility
diagnosis than nondrinkers.
Although the exact relationship between alcohol consumption on
conception is still under investigation, it is accepted that alcohol consumption is
not beneficial for those who are trying to conceive. For this reason, and for the
reason of conflicting literature, alcohol consumption should be included when
modeling likelihood of conception.

Primary vs. Secondary Infertility
Most studies that analyze the likelihood of conception find no association
with having at least one prior parity [2, 4, 6, 8, 9, 56, 60]. There are two studies,
however, that found associations of parity and likelihood of conception. The first
found that among infertile couples remaining untreated by ART, live birth rates
were positively associated with secondary infertility (HR = 1.83; 95% CI: 1.24 –
2.69) [57]. Similarly, the next study found that untreated couples with primary
infertility were achieving spontaneous conception slower than those couples with
secondary infertility (HR = 0.71, 95% CI: 0.56 – 0.90) [59]. Presumably, if a
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couple is fertile enough to conceive once, they should be more likely to conceive
than couples who have failed to ever achieve conception.

Duration of Infertility
Several studies have found significant associations between how long a
couple experiences infertility and the likelihood of conception and live births.
Across these analyses, varying durations are compared to estimate likelihood of
pregnancy. One study found that among untreated couples, when compared to
those with at least 36 months of infertility, couples with less than 36 months of
infertility were achieving live birth faster (HR = 1.68, 95% CI: 1.14 – 2.48) [57].
Another study found that among couples with unexplained infertility receiving
ART treatments, the duration of infertility was significantly different between
couples who achieved pregnancy and did not achieve pregnancy, with mean
durations of 20.2 months and 24.6 months, respectively (p-value < 0.001) [9].
Likewise, several other studies have shown that shorter durations of infertility are
significantly associated with higher likelihoods of conception and delivery [8, 55,
58, 59, 61], with one study having duration of infertility as the only significant
predictor of spontaneous conception among women receiving IVF [55].

Female age
The age of the female is one of the strongest predictors of pregnancy.
This is largely due to decline of function of the female reproductive system with
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increasing age. At the age of puberty, women embody 300,000 to 500,000
oocytes; at 37 years of age, only 25,000 oocytes; and roughly 1,000 at the age of
51 years [96]. The levels of FSH and AMH also change throughout a woman’s
life; gradually, FSH increases and AMH decreases with increased age [96]. As
mentioned in a separate section, increased FSH levels are associated with lower
pregnancy rates, as well as lower AMH levels [80]. The combination of fewer
oocytes, increased FSH levels, and decreased AMH levels results in slow but
significant decline of fecundity in women beginning around the age of 32 years,
and decreases rapidly after the age of 37 years [96]. Several studies have found
negative associations between female age and the likelihood of conception,
either spontaneous or while receiving ART [3, 4, 6, 8, 9, 56, 57, 59].
One retrospective study assessing subsequent spontaneous conceptions
after successful or unsuccessful IVF/ICSI treatments found a negative
association with female age and the likelihood of conception [8]. Among those
with prior successful IVF/ICSI treatments, when compared to women less than
30 years of age, women between the ages of 35 and 39 (OR = 0.30, 95% CI:
0.18 – 0.49) and women 40 or older (OR = 0.25, 95% CI 0.07 – 0.86) had
significantly less odds of spontaneously conceiving. Similarly, among women
with prior unsuccessful IVF/ICSI treatments, compared to those less than 30
years of age, women between 30 and 34 (OR = 0.50, 95% CI: 0.31 – 0.82),
between 35 and 39 (OR = 0.24, 95% CI: 0.14 – 0.43), and 40 or older (OR =
0.18, 95% CI: 0.09 – 0.38) had significantly less odds of spontaneously
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conceiving. Between both groups, a negative linear trend is present between
female age and likelihood of spontaneous conception.
Similarly, a study of infertile couples that have remained untreated, by
utilizing proportional hazards analysis, found that women less than 30 years old
were 50% more likely to conceive than women 30 years old or older (HR = 1.50,
95% CI: 1.05 – 2.16) [57]. A longitudinal study of couples with unexplained
infertility found that women who achieved spontaneous conception were
significantly younger than women who were not able to spontaneously conceive,
with mean ages of 31.3 and 34.1, respectively (p=<0.001) [9].
The clinical and epidemiological evidence shows that increased female
age results in decreased fecundity and decreased likelihood of conception. In
models of likelihood of conception, female age should always be controlled for,
and it is unsurprising when female age is significantly and negatively associated
with likelihood of conception.

Infertility diagnosis
Between varying studies, certain infertility diagnoses may be more
associated with the likelihood of conception than others. Several studies found
that different infertility diagnoses have significantly different associations with
spontaneous conception among varying populations of infertile couples, including
a study [2] of infertile couples after IVF treatments, regardless of their success
(p-value – 0.024), and another study [3] of infertile couples after only successful
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IVF treatments (p-value = 0.0535). When studies do show significant differences
in infertility diagnoses and conception or live birth rates, they do not consistently
result in the same diagnoses being associated with conception. However,
unexplained infertility seems to be the best diagnosis for likelihood of pregnancy.

Unexplained
Unexplained infertility seems to be the best diagnosis for likelihood of
conception. A retrospective internet survey study found that among women who
had discontinued IVF/ICSI, those with unexplained infertility were 2.82 times
more likely to spontaneously conceive than those with tubal damage (p = 0.005)
[7]. Another study found that among infertile couples who remained untreated by
ART, those with unexplained infertility were more than twice as likely to
spontaneously conceive than those with tubal infertility (HR = 2.64, 95% CI: 1.75
– 3.98) [59]. Further, one study found that couples with prior unsuccessful IVF
treatments and unexplained infertility are nearly 3 times higher odds of
conception than couples with male factor infertility and prior unsuccessful IVF
(OR = 2.98, 95% CI: 1.60 – 5.53) [8]. Several studies, with varying populations,
report that unexplained infertility is the infertility diagnosis with the highest
likelihood of conception or live birth [3, 5, 57, 59].

Male Factor
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In a study among untreated infertile couples, those with an infertility
diagnoses of male defect were having live births at less than half the rate of
those without a male defect diagnosis (HR = 0.47, 95% CI: 0.27 – 0.81) [57].
Interestingly, another study among untreated infertile couples found that couples
with male factor infertility were spontaneously conceiving 57% faster than those
with tubal factor infertility (HR = 1.57, 95% CI: 1.06 – 2.32) [59]. It should be
noted that in these analyses, one compared male factor infertility to no male
factor infertility, whereas the other compared male factor infertility to tubal factor
infertility, which could explain the conflicting results, even with both studies
among untreated infertile couples.

Endometriosis
Very little studies have found significant associations between
endometriosis and the likelihood of conception. One follow-up study found that,
among couples with prior live births from IVF/ICSI, those with an infertility
diagnosis of endometriosis had the highest rate of subsequent spontaneous
conception (28.3% of diagnosed conceived) [3]. However, another study found
that having endometriosis significantly lowered the time to spontaneous
conception (HR = 0.39, 95% CI: 0.18 – 0.85) among untreated infertile couples
when compared to couples without an endometriosis diagnosis [57]. Again, the
specific comparisons in each of these studies could be the reason behind the
conflicting results.
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Tubal Factor
Few studies have found significant associations between tubal factor
infertility and the likelihood of spontaneous conception or live birth, but those that
do find significant associations only report negative associations. One study
found that among untreated infertile couples, those with a tubal defect were
spontaneously conceiving in half the time of those without a tubal defect (HR =
0.50, 95% CI: 0.40 – 0.63) [57]. Similarly, another study of untreated infertile
couples found that a tubal factor infertility diagnosis significantly decreased the
likelihood of live birth after spontaneous conception (Relative likelihood = 0.14,
95% CI: 0.06 – 0.33) when compared to those with no tubal diagnosis [58].
Further, another study found that among couples who had discontinued IVF
treatments at least 3 years prior, those with tubal factor infertility were 7 times
less likely to spontaneously conceive (RR = 0.13, 95% CI: 0.03 – 0.52) when
compared to those with a diagnosis of “other” (mostly ovulatory factors), with only
6.3% of those with tubal factor infertility achieving conception [2].

Ovulation Factor
Among the literature, ovulation factor infertility seems to be negatively
associated with spontaneous conception. An internet survey study among
women who had discontinued IVF or ICSI treatments found that those women
with ovulation factor infertility had 2.58 times the odds (95% CI: 1.02 – 6.53) to
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conceive spontaneously when compared to the referent group of tubal infertility
[7]. A study of untreated infertile couples found similar findings, with couples
having a diagnosis of ovulation defect decreasing the likelihood of live birth after
spontaneous conception (Relative likelihood = 0.35, 95% CI: 0.21 – 0.58) when
compared to those with no ovulation defect [58]. Interestingly, however, one
study reports that having an infertility diagnosis of “other” (which the authors say
were mostly ovulatory diagnoses) had the highest rates of spontaneous
conception among couples who had discontinued IVF treatments at least 3 years
ago; 46.2% of women with the “other” diagnosis spontaneously conceived [2]. It
is unknown, however, just how much of this group, containing only 13 couples,
actually had an ovulatory factor diagnosis.

PCOS
Infertility diagnoses of PCOS are, to the best of my knowledge, not used in
current models of conception among infertile couples; it is assumed that if PCOS
diagnoses are included in these analyses, that it is part of an ovulatory factor
diagnosis. However, the current thesis will include PCOS as its own diagnosis,
as 39 (22.6%) participants have a clinical PCOS diagnosis, and 48 (27.9%) are
self-reporting PCOS. As mentioned in prior sections, PCOS is a Group II ovarian
factor infertility diagnosis, and accounts for 70% of infertility due to anovulation
[47]. An excess of free androgen and a decrease FSH contribute to the formation
of several pre-ovulatory follicles on the ovaries [47]. PCOS is associated with
obesity, as obesity-related insulin resistance can lower the amounts of FSH and
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increase the amounts of androgens [64]. Women with PCOS are twice as likely
to be overweight than women without PCOS [66].

Male age
Few studies utilize the male partner’s age as predictors of likelihood of
conception, and most of those that do find no association [8, 56, 57]. However,
one longitudinal cohort study found that among 437 couples with unexplained
infertility, those women who achieved pregnancy had partners of younger age
than those women who did not conceive, with mean male ages of 33.3 and 35.9,
respectively (p-value < 0.001) [9].

Sperm Volume and Sperm Motility
In a fairly recent follow-up study of women who had a prior successful live
birth as a result of IVF, those with partners of whom had higher concentrations of
sperm volume were more likely to conceive (p-value < 0.01) [5]. Likewise, the
women whose partners had higher sperm motility percentages were more likely
to conceive (p-value < 0.001). Another study of couples who had discontinued
ART, found that women who did not conceive were significantly more likely to
have partners with non-normal semen analyses than those women who did
conceive spontaneously (p-value = 0.03) [56]. These results could be interpreted
as infertility diagnosis; meaning that those couples with male factor infertility due
to non-normal sperm motility and volume are less likely to conceive
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spontaneously than those couples without male factor infertility, which has been
the result of prior mentioned papers [3, 57].

Number of ART Treatments
One retrospective study, of which utilized logistic regression, found that
women who had prior successful IVF treatments, having 2 to 4 treatment
attempts significantly decreased the odds of a subsequent live birth (OR
compared to 1 attempt = 0.65, 95% CI: 0.47 – 0.89) [8]. Likewise, having 5 to 14
attempts significantly decreased the odds of subsequent spontaneous live birth
(OR compared to 1 attempt = 0.44, 95% CI: 0.23 – 0.82). Similarly, among
women who had prior unsuccessful IVF treatments, having 2 to 4 IVF attempts
(OR compared to 1 attempt: 0.39, 95% CI: 0.26 – 0.60) or 5 to 14 IVF attempts
(OR compared to 1 attempt = 0.15, 95% CI: 0.07 – 0.32) significantly decreased
the odds of subsequent spontaneous live birth. Among both the successful and
unsuccessful IVF women, those who had only one attempt were more likely to
have a live birth as a result of spontaneous conception. These results seem to
suggest that those women of whom are fertile enough to conceive
spontaneously, do not require treatments; whereas those who are not fertile
enough to achieve spontaneous conception, would require several attempts.
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D. METHODS

LOUSSI Study Recruitment and Baseline Data Collection
For this thesis, data were used from the Louisville Tobacco Smoke
Exposure, Genetic Susceptibility, & Infertility Study (LOUSSI) (NICHD R15HS087911). The original purpose of the LOUSSI Study was to assess the effects
of smoking habits and NAT2 genotype on fertility. Participants were recruited at
the University of Louisville Reproductive Endocrinology and Infertility (REI) clinic
between September 2016 and June 2018 (N=264). A physician explained the
purpose of the study to the patients and if the patient expressed interest, a
LOUSSI team member explained the study in more detail. If the patient agreed,
informed consent was obtained (IRB number: 16.0063) and a $25 incentive was
extended. Exclusion criteria included being younger than 21 years of age, having
an ongoing pregnancy, inability to communicate in English, and having no
chance of achieving pregnancy i.e. hysterectomy, AMH levels nonexistent. Most
participants gave a urine sample, which was used to assay cotinine levels and
NAT2 genotype. All participants answered a smoking questionnaire to assess
current and past exposure to tobacco smoke and other nicotine products.
Demographic information and medical history (e.g., AMH levels, infertility
diagnoses, STI history, ART treatments, conception data) was extracted from
medical records. Baseline variables included age, BMI, race, blood pressure, age
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at menarche, smoking status/amount, alcohol use/amount, and drug use. All
other variables were collected from patient history forms or medical records.
Permission to recontact participants began at participant #100.

Follow-Up Data Collection
Participants that gave permission for recontact were followed up with an
email at least 6 months after enrolling into the LOUSSI Study. If not reached by
email, participants were contacted by phone. For working phone numbers, up to
3 attempts were made to contact each participant by phone. Still, if contact was
not made, they were mailed a paper questionnaire with a pre-addressed and prestamped return envelope. For those participants who were never recontacted,
and for those of whom were never asked to be recontacted, pregnancy data was
extracted from medical records.
Conception was defined as having achieved a clinical pregnancy by a
positive pregnancy test, regardless of its outcome. The conception date was
defined as the month after the last menstrual period as reported by the
participants, or nine months before the due date as reported by the participant.
From the medical records, the conception date was defined as either the
conception date as recorded by the physician, or the month after the last
menstrual period as recorded by the physician. ART treatments after initial
enrollment were also extracted from medical records.

Descriptive Statistics
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All statistics were determined by SAS Software (9.4). Three sub-samples
were included for analysis: the total population, and the total population stratified
by ART status (ever versus never). Descriptive statistics were analyzed in four
ways, by which all variables were examined for an association with pregnancy
(any versus none) in each of the three sub-samples, as well for an association
with STI history (any versus none). Chi-square and Fisher’s Exact test were
reported; Fisher’s Exact test was reported when the expected value was less
than 5 for at least 25% of the cells. Significant associations were defined by a
Chi-square or Fisher’s Exact p-value of 0.05 or less.

Etiologic Logistic Regression Modeling
Treatment of variables for modeling are shown in Table 2.
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Table 2: Variable Definitions and Treatment in Modeling
Variable
Age

Categories (where applicable)
*<=32
>=33

Obesity

*BMI < 30
BMI >= 30

Race

Dummy variables
*White

Yes/No

Black

Yes/No

Other

Yes/No

Blood Pressure

Alcohol Use

*Low: Systolic BP < 120 and Diastolic BP < 80
Medium: Systolic BP between 120-129 and Diastolic BP < 80
High: Systolic BP >= 130 and Diastolic BP < 89
Yes/*No

Smoker
Smoker = cotinine level >= 100 or self-report of smoking
*Non-Smoker = cotinine level < 100 and no self-report of smoking
ln(AMH)

Continuous

Tubal Diagnosis

Yes/*No

Uterine Diagnosis

Yes/*No

Ovarian Diagnosis

Yes/*No

Male Diagnosis

Yes/*No

PCOS Diagnosis

Yes/*No

History of STI

Yes/*No

History of HPV

Yes/*No

History of Chlamydia

Yes/*No

ART during Cycle

Yes/*No
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To determine the effects of STI history on the likelihood of conception,
logistic regression models were performed on the three sub-samples of the
current population: 1) on the entire 170 women in the follow-up population; 2) on
women who did not receive any ART treatment during the entire follow up; and 3)
on women who received ART treatment at least once during the follow up. The
dichotomous outcome for all models was pregnancy, with history of any STI
being the main exposure of interest. Variables to be initially included in each
model were chosen by a Chi-square or Fisher’s Exact test p-value <= 0.2 in the
bivariable analysis with either STI history or pregnancy in the relevant population.
For example, for a variable to be included in the model of women with no ART
treatments, the variable had a p-value <= 0.2 when compared to STI history or
when compared to pregnancies among the sub-sample with no ART treatments.
Because of the overwhelming evidence in the literature for the effects of older
age and obesity on reduced fertility, age and obesity were included in all models,
regardless of their descriptive statistic p-value.
Continuous variables were assessed for a dose-response by examining
multiple categories’ effects on the outcome. If a dose-response was found, then
the variable was treated continuously. If a threshold effect was detected, similar
categories were combined. Two-way interaction terms were tested in each model
by including product terms. However, in all three models, all interactions were
statistically non-significant, and therefore no interaction terms were kept in any
model.
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A data-based method for assessing confounding was used. Confounders
were defined as those variables that changed the OR for STI by more than 10%
when removed from the model. Variables that were not confounders were
examined for their effect on the precision of the effect of STI (i.e., the width of the
95% confidence interval for STI). If a variable removed from the model changed
the OR of STI on pregnancy by less than 10%, but increased precision, the
variable was retained. Age and obesity were forced into the model due to the
abundance of evidence of a strong association with fertility. Multicollinearity was
tested several times throughout each modeling process by examining the
variance decomposition proportions for all variables. Lastly, a HosmerLemeshow test was conducted on each of the final models to determine
goodness of fit. Models were determined to be of good fit when the HosmerLemeshow test p-value was greater than 0.05, of which all final models exhibited.
AMH was log-transformed (ln(AMH)) due to the skewed distribution of the
variable.
Additionally, the variable for a uterine infertility diagnosis was not included
in the testing of all models, as only nine participants had a uterine diagnosis.
Likewise, the unknown diagnosis variable was excluded from the models of those
who ever received ART, as only six participants in this sub-sample had this
specific diagnosis.

Predictive Logistic Regression Modeling
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To determine which factors were associated with the odds of pregnancy,
predictive logistic regression models were performed, with pregnancy being the
dichotomous outcome. Similar to the etiologic regression models, three predictive
regression models were performed on the three sub-samples of the study. All
variables were tested to determine their inclusion in the model, as well as several
interaction terms. However, variables with a p-value of 0.2 or less were chosen to
be initially included in the model, and after a stepwise analysis, those variables
with a p-value of 0.2 or less were retained in the final model. Based on the
evidence of a strong association with fertility, age and obesity were forced into
each model, regardless of their respective p-values. Finally, a HosmerLemeshow goodness of fit test was performed on all final models, and models
were determined to be of good fit if the test p-value was greater than 0.05.
Across all logistic regression analyses, significance is defined by a p-value of
0.05 or less.
It should also be noted that in two of the sub-samples, AMH levels were
missing for 20 participants; for these two sub-samples, models were first tested
with the AMH variable included to determine if AMH would be selected for the
final model. Neither of the two models included AMH, so a second test was
performed excluding the AMH variable, which resulted in final predictive models
with larger sample sizes. For the third sample, those who ever received ART, all
AMH values were present.

Survival Analyses
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Follow-up data was used to determine the time to pregnancy. The start
time was defined as the enrollment month of the participant – time 0, whereas
the end time was either 1) the last medical record entry, 2) the conception date,
3) the last contact with the participant, or 4) the last month that the participant
was actively trying to achieve pregnancy. ART was included as a time-varying
covariate.
Six separate survival analyses were conducted, respective to the six
logistic regression performed: etiologic models with history of STI as the main
exposure of interest among the three sub-samples, as well as predictive models
among the three sub-samples. Variables to be included for testing in each
survival analysis were those variables that were included in the final models of
the respective logistic regressions. Across all survival analyses, significance is
defined by a p-value of 0.05 or less.
The Proportional Hazards Assumption was assessed for each variable
included in each of the six models. For those variables that violated the
assumption, either by a correlation between Schoenfeld residual and time pvalue of less than 0.05 or by examining their log-negative log curves, models
were adjusted for the violating variable by either stratification or inclusion of an
interaction term with time.
Time-varying data was used with ART per cycle (yes/no) being the timevarying covariate. In the two models produced for the sub-sample among those
with no ART, the time-varying ART variable was not included; none of the women
had ever received ART treatments, therefore none of the women had any value
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for ART other than 0. However, in the models produced for the entire population
and for the sub-sample of women who ever received ART, the time-varying ART
variable was included, and hazard ratio estimates could be produced.
Among the four models in which the time-varying ART variable was
included, determination of whether the ART variable met the Proportional
Hazards assumption was tested by the production of an extended Cox model
adjusting for all other covariates; if the ART*time variable had a significant pvalue, it was considered to be significantly associated with time, and the final
model was stratified by ART.
Kaplan-Meier survival curves were produced for all variables present in
each model. Additionally, for each of the three etiologic models, adjusted survival
curves were created for STI, controlling for all other variables in each model.
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E. RESULTS

Of the 264 participants in the entire LOUSSI cohort, follow-up data was
successfully collected for 170 (64.4%), either by extraction of medical records
from a follow-up visit at the Fertility Clinic, and/or by direct recontact for those of
whom permission was obtained (requested of participants 100-264) (Figure 1). 6
participants from the second group (numbers 100-264) declined to be
recontacted; therefore, we obtained permission to recontact 157 people.

Of these 170 women, 82 (48.2%) never received an ART treatment after
enrolling in the LOUSSI Study, and 88 (51.8%) received at least one cycle of
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ART treatment (Figure 2). There were 76 (44.7%) women who achieved at least
one pregnancy since enrollment. Among those women who never received ART,
32 (39.0%) achieved a spontaneous pregnancy. Among those women who ever
received ART, 44 (50%) achieved a pregnancy, of which 35 (79.5%) were
through the means of ART, and 9 (20.5%) were spontaneous conceptions.

Descriptive Statistics by Conception Status Among all Sub-Samples
Table 3 shows the characteristics of all the women (N=170) included in
this study stratified by pregnancy status (any vs. none). Those women who did
achieve pregnancy were younger and less likely to be obese. However, these
differences were not statistically significant. Women who achieved a pregnancy
had lower cotinine levels (P-value = 0.019), had higher AMH levels (P-value =
0.004), and were more likely to have an ovarian (P-value = 0.024) or a PCOS (Pvalue = 0.041) infertility diagnosis than women who did not conceive.
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Table 3: Characteristics Among Entire Follow-Up
Stratified by Conception Status (N=170)
Any
Conception
N (%)
N=76

No
Conception
N (%)
N=94

<=27
28 - 32
33 - 37
>37

24 (31.58)
19 (25.00)
19 (25.00)
14 (18.42)

20 (21.28)
22 (23.40)
30 (31.91)
22 (23.40)

<18.5
18.5 - 24.9
25.0 - 29.9
>=30
Race
White
Black
Asian
Native American
Middle Eastern
Hispanic
Diastolic BP
<80
80-89
>=90

1 (1.32)
20 (26.32)
26 (34.21)
29 (38.16)

3 (3.19)
18 (19.15)
24 (25.53)
49 (52.12)

46 (60.53)
14 (18.42)
5 (6.58)
1 (1.32)
2 (2.63)
8 (10.53)

50 (53.19)
32 (34.04)
6 (6.38)
0 (0.00)
0 (0.00)
6 (6.38)

45 (59.21)
25 (32.89)
6 (7.89)

53 (56.38)
22 (23.40)
19 (20.21)

33 (43.42)
19 (25.00)
17 (22.37)
7 (9.21)

38 (40.43)
24 (25.53)
20 (21.28)
12 (12.77)

35 (46.05)
41 (53.95)

45 (47.87)
49 (52.12)

46 (60.53)
12 (15.79)
18 (23.68)

56 (59.57)
20 (21.28)
18 (19.15)

39 (51.32)
37 (48.68)

59 (62.77)
35 (37.23)

Age

BMI

ChiSquare
or Fisher
Exact
p-value
0.398

0.219

Systolic BP
< 120
120-129
130-139
>= 140
Alcohol
Yes
No
Alcoholic Drinks
per Week
0
0-1
>1

0.091

0.056

0.898

0.813

0.581

Caffeine Drinks
per Day
<=1
>=2

0.133
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Self-Report
Smoker
Yes
No
Packs per Day
0
<1
>=1

0.224
10 (13.16)
66 (86.84)

19 (20.21)
75 (79.79)
0.310

66 (86.84)
5 (6.58)
5 (6.58)

75 (79.79)
13 (13.83)
6 (6.38)

32 (42.11)
24 (31.58)
20 (26.32)

47 (50.00)
13 (13.83)
34 (36.17)

Cotinine Level
(ng/mL)
<1
1-10
>10

0.019

AMH Level
(ng/mL)
<0.3
0.3-0.6
0.7-0.9
1-2.9
>=3

0.004
6 (8.57)
0 (0.00)
6 (8.57)
25 (35.71)
33 (47.14)

11 (13.75)
7 (8.75)
0 (0.00)
30 (37.50)
32 (40.00)

Duration of
Infertility
(months)
<12
13-24
25-48
>= 48
Age at Menarche
(years)

32 (42.11)
17 (22.37)
9 (11.84)
18 (23.68)

7-10.9
11-12.9
13-14
>14

9 (11.84)
26 (34.21)
21 (27.63)
20 (26.32)

13 (14.77)
32 (36.36)
20 (22.73)
23 (26.14)

44 (57.89)
32 (42.11)

44 (46.81)
50 (53.19)

0.844
42 (44.68)
16 (17.02)
13 (13.83)
23 (24.47)
0.872

ART

0.150

Yes
No
Illicit Drug Use
Yes
No

0.382
1 (1.33)
74 (98.67)

4 (4.30)
89 (95.70)

Unexplained
Diagnosis
Yes
No

0.458
12 (15.79)
64 (84.21)

19 (20.21)
75 (79.79)

Tubal Factor
Diagnosis
Yes

0.059
5 (6.58)

15 (15.96)
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No

71 (93.42)

79 (84.04)

Uterine
Diagnosis
Yes
No

0.302
6 (7.89)
70 (92.11)

3 (3.19)
91 (96.81)

Ovarian
Diagnosis
Yes
No

0.024
21 (27.63)
55 (72.37)

13 (13.83)
81 (86.17)

Male Factor
Diagnosis
Yes
No
PCOS Diagnosis
Yes
No
Other Diagnosis
Yes
No

0.148
16 (21.05)
60 (78.95)

12 (12.77)
82 (87.23)

23 (30.26)
53 (69.74)

16 (17.02)
78 (82.98)

0.041

1.000
1 (1.32)
75 (98.68)

2 (2.13)
92 (97.87)

Unknown
Diagnosis
Yes
No

0.230
15 (19.74)
61 (80.26)

26 (27.66)
68 (72.34)

History of STI
Yes
No

29 (38.16)
47 (61.84)

35 (37.23)
59 (62.77)

History of
Chlamydia
Yes
No

13 (17.11)
63 (82.89)

23 (24.47)
71 (75.53)

1 (1.32)
75 (98.68)

6 (6.38)
88 (93.62)

History of
Gonorrhea
Yes
No
History of HPV
Yes
No
History of
Herpes
Yes
No

0.902

0.243

0.132

0.147
14 (18.42)
62 (81.58)

10 (10.64)
84 (89.36)
0.462

2 (2.63)
74 (97.37)

5 (5.32)
89 (94.68)

Characteristics among women who never received ART treatments
(N=82) are shown in Table 4. Among this sub-sample, women who achieved a
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pregnancy were younger and less obese, but again, not significantly. Women
who did not achieve pregnancy had higher diastolic blood pressure. Those who
achieved pregnancy were comparable to those who did not achieve pregnancy in
all comparisons.
Table 4: Characteristics Among Those with No ART
Stratified by Conception Status (N=82)
ChiAny
No
Square
Conception Conception
or
N (%)
N (%)
Fisher
N=32
N=50
Exact
p-value
Age
0.428
<=27
14 (43.75)
14 (28.00)
28 - 32
8 (25.00)
14 (28.00)
33 - 37
5 (15.63)
14 (28.00)
>37
5 (15.63)
8 (16.00)
BMI
0.150
<18.5
0 (0.00)
3 (6.00)
18.5 - 24.9
9 (28.13)
13 (26.00)
25.0 - 29.9
11 (34.38)
8 (16.00)
>=30
12 (52.00)
26 (52.00)
Race
0.359
White
14 (43.75)
25 (50.00)
Black
9 (28.13)
18 (36.00)
Asian
4 (12.50)
4 (8.00)
Native American
0 (0.00)
0 (0.00)
Middle Eastern
2 (6.25)
0 (0.00)
Hispanic
3 (9.38)
3 (6.00)
Diastolic BP
0.058
<80
21 (65.63)
28 (56.00)
80-89
10 (31.25)
11 (22.00)
>=90
1 (3.13)
11 (22.00)
Systolic BP
< 120
120-129
130-139
>= 140
Alcohol
Yes
No

0.799
16 (50.00)
8 (25.00)
6 (18.75)
2 (6.25)

21 (42.00)
14 (28.00)
9 (18.00)
6 (12.00)
0.133

10 (31.25)
22 (68.75)

24 (48.00)
26 (52.00)
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Alcoholic
Drinks per
Week
0
0-1
>1

0.305
25 (78.13)
3 (9.38)
4 (12.50)

31 (62.00)
9 (18.00)
10 (20.00)

Caffeine Drinks
per Day
<=1
>=2

0.902
19 (59.38)
13 (40.63)

29 (58.00)
21 (42.00)

Self-Report
Smoker
Yes
No
Packs per Day
0
<1
>=1

0.258
7 (21.88)
25 (78.13)

16 (32.00)
34 (68.00)

25 (78.13)
5 (15.63)
2 (6.25)

34 (68.00)
10 (20.00)
6 (12.00)

0.618

Cotinine Level
(ng/mL)
<1
1-10
>10

0.480
12 (37.50)
7 (21.88)
13 (40.63)

20 (40.00)
6 (12.00)
24 (48.00)

4 (15.38)
0 (0.00)
2 (7.69)
9 (34.62)
11 (42.31)

6 (16.67)
0 (0.00)
0 (0.00)
14 (38.89)
16 (44.44)

14 (43.75)
9 (28.13)
6 (18.75)
3 (9.38)

21 (42.00)
10 (20.00)
6 (12.00)
13 (26.00)

AMH Level
(ng/mL)
<0.3
0.3-0.6
0.7-0.9
1-2.9
>=3
Duration of
Infertility
(months)
<12
13-24
25-48
>= 48
Age at
Menarche
(years)
7-10.9
11-12.9
13-14
>14
Illicit Drug Use
Yes
No

0.514

0.268

0.968
6 (18.75)
11 (34.38)
7 (21.88)
8 (25.00)

8 (17.02)
16 (34.04)
9 (19.15)
14 (29.79)

1 (3.23)
30 (96.77)

4 (8.16)
45 (91.84)

0.644
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Unexplained
Diagnosis
Yes
No

0.396
1 (3.13)
31 (96.88)

5 (10.00)
45(90.00)

2 (6.25)
30 (93.75)

10 (20.00)
40 (80.00)

1 (3.13)
31 (96.88)

2 (4.00)
48 (96.00)

9 (28.13)
23 (71.88)

9 (18.00)
41 (82.00)

6 (18.75)
26 (81.25)

3 (6.00)
47 (94.00)

8 (25.00
24 (75.00)

8 (16.00)
42 (84.00)

Tubal Factor
Diagnosis
Yes
No

0.114

Uterine
Diagnosis
Yes
No

1.000

Ovarian
Diagnosis
Yes
No

0.280

Male Factor
Diagnosis
Yes
No
PCOS
Diagnosis
Yes
No
Other
Diagnosis
Yes
No

0.144

0.316

1.000
0 (0.00)
32 (100)

1 (2.00)
49 (98.00)

Unknown
Diagnosis
Yes
No

0.876
14 (43.75)
18 (56.25)

21 (42.00)
29 (58.00)

History of STI
Yes
No

12 (37.50)
20 (62.50)

18 (36.00)
32 (64.00)

History of
Chlamydia
Yes
No

6 (18.75)
26 (81.25)

11 (22.00)
39 (78.00)

1 (3.13)
31 (96.88)

3 (6.00)
47 (94.00)

History of
Gonorrhea
Yes
No
History of HPV
Yes
No

0.891

0.723

1.000

0.674
3 (9.38)
29 (90.63)

3 (6.12)
47 (94.00)
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History of
Herpes
Yes
No

0.396
1 (3.13)
31 (96.88)

5 (10.00)
45 (90.00)

Table 5 displays the characteristics among women who ever received
ART (N=88) after enrollment. Similar to the other sub-samples, those who
achieved pregnancy were generally younger and less obese, but not significantly.
Those who did become pregnant had significantly higher AMH levels (P-value =
0.005) and were significantly more likely to have an ovarian infertility diagnosis
(P-value = 0.027).
Table 5: Characteristics Among Those with ART
Stratified by Conception Status (N=88)
ChiAny
No
Square
Conception Conception
or
N (%)
N(%)
Fisher
N=44
N=44
Exact
p-value
Age
0.441
<=27
10 (22.73)
6 (13.64)
28 - 32
11 (25.00)
8 (18.18)
33 - 37
14 (31.82)
16 (36.36)
>37
9 (20.45)
14 (31.82)
BMI
0.242
<18.5
1 (2.27)
0 (0.00)
18.5 - 24.9
11 (25.00)
5 (11.36)
25.0 - 29.9
15 (34.09)
16 (36.36)
>=30
17 (52.27)
23 (52.27)
Race
0.090
White
32 (72.73)
25 (56.82)
Black
5 (11.36)
14 (31.82)
Asian
1 (2.27)
2 (4.55)
Native American
1 (2.27)
0 (0.00)
Middle Eastern
0 (0.00)
0 (0.00)
Hispanic
5 (11.36)
3 (6.82)
Diastolic BP
0.515
<80
24 (54.55)
25 (56.82)
80-89
15 (34.09)
11 (25.00)
>=90
5 (11.36)
8 (18.18)
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Systolic BP
< 120
120-129
130-139
>= 140
Alcohol
Yes
No
Alcoholic Drinks
per Week
0
0-1
>1

0.987
17 (38.64)
11 (25.00)
11 (25.00)
5 (11.36)

17 (38.64)
10 (22.73)
11 (25.00)
6 (13.64)

25 (56.82)
19 (43.18)

21 (47.73)
23 (52.27)

21 (47.73)
9 (20.45)
14 (31.82)

25 (56.82)
11 (25.00)
8 (18.18)

0.393

0.336

Caffeine Drinks
per Day
<=1
>=2

0.031
20 (45.45)
24 (54.55)

30 (68.18)
14 (31.82)

Self-Report
Smoker
Yes
No
Packs per Day
0
<1
>=1

1.000
3 (6.82)
41 (93.18)

3 (6.82)
41 (93.18)

41 (93.18)
0 (0.00)
3 (6.82)

41 (93.18)
3 (6.82)
0 (0.00)

0.058

Cotinine Level
(ng/mL)
<1
1-10
>10

0.057
20 (45.45)
17 (38.64)
7 (15.91)

27 (61.36)
7 (15.92)
10 (22.73)

2 (4.55)
0 (0.00)
4 (9.09)
16 (36.36)
22 (50.00)

5 (11.36)
7 (15.91)
0 (0.00)
16 (36.36)
16 (36.36)

18 (40.91)
8 (18.18)
3 (6.82)
15 (34.09)

21 (47.73)
6 (13.64)
7 (15.91)
10 (22.73)

AMH Level
(ng/mL)
<0.3
0.3-0.6
0.7-0.9
1-2.9
>=3
Duration of
Infertility
(months)
<12
13-24
25-48
>= 48
Age at Menarche
(years)

0.005

0.374

0.742
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7-10.9
11-12.9
13-14
>14
Illicit Drug Use
Yes
No

3 (6.82)
15 (34.09)
14 (31.82)
12 (27.27)

5 (12.20)
16 (39.02)
11 (26.83)
9 (21.95)
-

0 (0.00)
44 (100)

0 (0.00)
44 (100)

Unexplained
Diagnosis
Yes
No

0.478
11 (25.00)
33 (75.00)

14 (31.82)
30 (68.18)

Tubal Factor
Diagnosis
Yes
No
Uterine
Diagnosis
Yes
No

0.713
3 (6.82)
41 (93.18)

5 (11.36)
39 (88.64)

5 (11.36)
39 (88.64)

1 (2.27)
43 (97.73)

12 (27.27)
32 (72.73)

4 (9.09)
40 (90.91)

10 (22.73)
34 (77.27)

9 (20.45)
35 (79.55)

15 (34.09)
29 (65.91)

8 (18.18)
36 (81.82)

1 (2.33)
42 (97.67)

1 (2.22)
44 (97.78)

1 (2.27)
43 (97.73)

5 (11.36)
39 (88.64)

History of STI
Yes
No

17 (39.53)
27 (60.47)

17 (39.53)
27 (60.47)

History of
Chlamydia
Yes
No

7 (15.91)
37 (84.09)

12 (27.27)
32 (72.73)

0.202

Ovarian
Diagnosis
Yes
No

0.027

Male Factor
Diagnosis
Yes
No
PCOS Diagnosis
Yes
No
Other Diagnosis
Yes
No

0.796

0.089

1.000

Unknown
Diagnosis
Yes
No

0.202

1.000

0.195

History of
Gonorrhea

0.241
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Yes
No
History of HPV
Yes
No
History of
Herpes
Yes
No

0 (0.00)
44 (100)

3 (6.82)
41 (93.18)
0.291

11 (25.00)
33 (75.00)

7 (15.91)
37 (84.09)

1 (2.27)
43 (97.73)

0 (0.00)
44 (100)

1.000

Descriptive Statistics by STI Status
Among the total sample of 170 women, 64 (37.6%) had a history of any
STI, whereas 106 (62.4%) had no history of any STI. The 64 with a history of any
STI consisted of 36 chlamydia infections, 7 gonorrhea infections, 24 HPV
infections, and 7 herpes infections, totaling 74 past STI infections (some
participants had a history of more than one STI). Among these 64 women, 29
(45.3%) achieved a pregnancy, 12 (41.4%) of which were women who never
received ART and 17 (58.6%) of which had received ART.
In Table 6, characteristics of the entire sample stratified by STI history is
shown. Those with a history of STI were more likely to be non-white (P-value =
0.013) and consume alcohol (P-value = 0.002). Additionally, those with a history
of STI were more likely to have a tubal infertility diagnosis (P-value = 0.028), but
less likely to have an ovarian infertility diagnosis (P-value = 0.022).

Table 6: Characteristics Among Entire Follow-Up Stratified
by History of STI (N=170)
History of
Any STI
N (%)
N=64

No History
of STI
N (%)
N=106

Age

Chi-Square
or Fisher
Exact
p-value
0.413

<=27

12 (18.75)

32 (30.19)
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28 - 32
33 - 37
>37

16 (25.00)
21 (32.81)
15 (23.44)

25 (23.58)
28 (26.42)
21 (19.81)

<18.5
18.5 - 24.9
25.0 - 29.9
>=30
Race
White
Black
Asian
Native American
Middle Eastern
Hispanic
Diastolic BP
<80
80-89
>=90

1 (1.56)
14 (21.88)
18 (28.13)
31 (48.44)

3 (2.83)
24 (22.64)
32 (30.19)
47 (44.34)

BMI

0.969

Systolic BP
< 120
120-129
130-139
>= 140
Alcohol
Yes
No
Alcoholic Drinks
per Week
0
0-1
>1

0.013
31 (48.44)
27 (42.19)
3 (4.69)
0 (0.00)
0 (0.00)
3 (4.69)

65 (61.32)
19 (17.92)
8 (7.55)
1 (0.94)
2 (1.89)
11 (10.38)

36 (56.25)
19 (29.69)
9 (14.06)

62 (58.49)
28 (26.42)
16 (15.09)

26 (40.63)
19 (29.69)
13 (20.31)
6 (9.38)

45 (42.45)
24 (22.64)
24 (22.64)
13 (12.26)

0.897

0.750

0.002
40 (62.50)
24 (37.50)

40 (37.74)
66 (62.26)
0.055

31 (48.44)
15 (23.44)
18 (28.13)

71 (66.98)
17 (16.04)
18 (16.98)

Caffeine Drinks
per Day
<=1
>=2

0.775
36 (56.25)
28 (43.75)

62 (58.49)
44 (41.51)

Self-Report
Smoker
Yes
No
Packs per Day
0
<1
>=1

0.086
15 (23.44)
49 (76.56)

14 (13.21)
92 (86.79)
0.151

49 (76.56)
8 (12.50)
7 (10.94)

92 (86.79)
10 (.43)
4 (3.77)

Cotinine Level
(ng/mL)

0.524
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<1
1-10
>10

31 (48.44)
11 (17.19)
22 (34.38)

48 (45.28)
26 (24.53)
32 (30.19)

AMH Level
(ng/mL)

0.228

<0.3
0.3-0.6
0.7-0.9
1-2.9
>=3
Duration of
Infertility
(months)
<12
13-24
25-48
>= 48
Age at Menarche
(years)

3 (5.36)
2 (3.57)
4 (7.14)
23 (41.07)
24 (42.86)

14 (14.89)
5 (5.32)
2 (2.13)
32 (34.04)
41 (43.62)

7-10.9
11-12.9
13-14
>14

6 (9.52)
26 (41.27)
14 (22.22)
17 (26.98)

16 (15.84)
32 (31.68)
27 (26.73)
26 (25.74)

34 (53.13)
30 (46.88)

54 (50.94)
52 (49.06)

0.381
30 (46.88)
10 (15.63)
11 (17.19)
12 (20.31)

44 (41.52)
23 (21.70)
11 (10.38)
28 (26.42)
0.475

ART

0.783

Yes
No
Illicit Drug Use
Yes
No

0.359
3 (4.84)
59 (95.16)

2 (1.89)
104 (98.11)

Unexplained
Diagnosis
Yes
No

0.586
13 (20.13)
51 (79.69)

18 (16.98)
88 (83.02)

Tubal Factor
Diagnosis
Yes
No
Uterine
Diagnosis
Yes
No

0.028
12 (18.75)
52 (81.25)

8 (7.55)
98 (92.45)
0.730

4 (6.25)
60 (93.75)

5 (4.72)
101 (95.28)

Ovarian
Diagnosis
Yes
No

0.022
7 (10.94)
57 (89.06)

27 (25.47)
79 (74.53)

Male Factor
Diagnosis

0.278
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Yes
No
PCOS Diagnosis
Yes
No
Other Diagnosis
Yes
No

8 (12.50)
56 (87.50)

20 (18.87)
86 (81.13)
0.078

10 (15.63)
54 (84.38)

29 (27.36)
77 (72.64)

0 (0.00)
64 (100)

3 (2.83)
103 (97.17)

0.292

Unknown
Diagnosis
Yes
No
Conception
Yes
No

0.563
17 (26.56)
47 (73.44)

24 (22.64)
82 (77.36)
0.902

29 (45.31)
35 (54.69)

47 (44.34)
59 (55.66)

Specific Aim 1 Results
1a: To estimate the effect of STI history on the probability of pregnancy.
Among all sub-samples, variables included in initial modeling were those
associated with either history of STI or pregnancy (P-value<=0.20). Age and
obesity were also included, regardless of P-value, because of their established
association with probability of conception. History of STI was the exposure of
interest. Using a data-based method, confounders were identified and retained in
the model, while non-confounders were removed.
Among the entire cohort (N=170), variables initially included were history
of STI, age, obesity, blood pressure, race, alcohol use, smoking status, AMH
levels, and infertility diagnoses of tubal, ovarian, PCOS, or male. The final model
included the following variables: history of STI, age, obesity, race, ovarian
infertility diagnosis (Table 7). In the resulting model, those with a history of STI
had 1.56 times the odds of achieving pregnancy compared with those without a
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history of STI, adjusted for age, BMI, race, and ovarian diagnosis. However, this
estimate is nonsignificant (95% CI = 0.77 - 3.13).
Among the sub-sample of women with no ART (N=82), initial variables
included history of STI, age, obesity, blood pressure, alcohol use, race, smoking
status, and infertility diagnoses of tubal, ovarian PCOS, or male. The final model
only included the variables of history of STI age, obesity, blood pressure, alcohol
use, and tubal and ovarian infertility diagnoses (Table 7). Adjusting for these
variables, those women with a history of STI had 2.75 times the odds of
conceiving than those without a history of STI, although not significantly (95% CI:
0.86 - 8.77). Additionally, an effect mediation analysis was conducted on this
specific sub-sample, as tubal infertility diagnosis was retained in the model and is
known to be caused by certain STIs. However, when the variable was taken out,
there was no significant change in the effect measure of STI.
Lastly, among the sub-sample of women with ART (N=88), initial variables
were history of STI, age, obesity, alcohol use, smoking status, AMH levels, and
infertility diagnoses of tubal, ovarian, PCOS, and uterine. Variables retained in
the final model included the following: history of STI, age, obesity, and race
(Table 7). In this resulting model, those women with a history of STI had 1.19
times the odds of achieving pregnancy than those women without a history of STI
(95% CI: 0.46 - 3.11).
After confounding assessments, the effect of STI on the probability of
pregnancy among each sub-sample are shown in Table 8.
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Table 7: Final Logistic Regression Models for the Effect of History of STI on the Probability of Pregnancy Among Each Sub-Sample
Log (odds of Pregnancy) = β0+ β1*History of STI + β2*Age + β3*Obesity + β4*Black❊ + β5*Other Race❊+ β6*Ovarian
Diagnosis

Entire Cohort
(N=170)

Log (odds of Pregnancy) = β0+ β1*History of STI + β2*Age + β3*Obesity + β4*Blood Pressure2 + β5*Blood Pressure3 +
β6*Alcohol Use + β7*Tubal Diagnosis + β8*Ovarian Diagnosis

No ART (N=82)

Log (odds of Pregnancy) = β0+ β1*History of STI + β2*Age + β3*Obesity + β4*Black❊ + β5*Other Race❊
ART (N=88)
❊
White = reference group

72
Table 8: Odds Ratios for the Effect of History of STI on
Pregnancy Among All Sub-Samples
Entire Cohort (N=170)a
b

No ART (N=82)
With ART (N=88)c

OR (95% CI)

P-value

1.56 (0.77 - 3.13)

0.211

2.75 (0.86 - 8.77)
1.19 (0.46 - 3.11)

0.088
0.713

a

Adjusted for age, obesity, race, ovarian infertility diagnosis.
Adjusted for age, obesity, blood pressure, alcohol use, tubal infertility diagnosis, ovarian infertility diagnosis.
c Adjusted for age, obesity, race.
b

72

1b: To estimate the effect of STI history on the time to pregnancy.
To determine the effect of history of STI on time to pregnancy, Cox
models were produced for each sub-sample. Variables included in each model
were those that were retained in the respective logistic regression models from
Specific Aim 1a. A time-varying variable of ART per cycle was also included in
sub-samples #1 and #3, those of which contained ART cycles.
Among sub-sample #1, the entire cohort (N=170), none of the variables
tested by correlation of residuals with time, or by examining ln(-ln) curves,
violated the Proportional Hazards assumption. When producing the Cox model,
the interaction of ART cycles*time was significant, meaning that the time-varying
covariate of ART violated the Proportional Hazards assumption; the final Cox
model was stratified by the ART cycles variable. In the resulting model, women
with a history of STI became pregnant 1.27 times faster than those without a
history of STI. However, this estimate was not significant. Cox survival curves of
history of STI adjusted for all variables in the model (younger than 32, not obese,
white, no ovarian infertility diagnosis) are shown in Figure 3.
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In sub-sample #2, those women who never received ART (N=82), history
of STI violated the Proportional Hazards assumption (Figure 4). No other
variables violated the Proportional Hazards assumption. Because history of STI
is the main exposure of interest, an extended Cox model was produced. The final
Cox model was adjusted for all other variables included in the model and
included Heaviside functions for history of STI before 6 months of follow-up time
and at or after 6 months of follow-up time. Those women with a history of STI
were becoming pregnant 5.51 times faster, significantly, than those without a
history of STI before 6 months of follow up. From 6 months and later, those
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women with a history of STI were nonsignificantly becoming pregnant 30%
slower than those without a history of STI.

In the cohort of women who ever received ART during treatment, subsample #3 (N=88), none of the constant variables violated the Proportional
Hazards assumption. However, the ln(-ln) curves of obesity (Figure 5) were
questionable, so an extended Cox model was produced with Heaviside functions
dichotomized at 6 months of follow-up time. Similar to sub-sample #1, when
ARTcycles*time was significant, and therefore the ART cycle variable violated
the Proportional Hazards assumption. The final extended Cox model was
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stratified by the time-varying ART covariate, adjusted for all other variables, and
included Heaviside functions for obesity and time. Women with a history of STI
achieved pregnancy 28% faster than those without a history of STI, though this
was not statistically significant (HR = 1.28, 95% CI = 0.67 – 2.47). Cox survival
curves for history of STI adjusted for all other variables (younger than 32, not
obese, white) are shown in Figure 6.
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The effect of STI on the time of pregnancy among each sub-sample are
shown in Table 9.
Table 9: Hazard Ratios for the Effect of History of STI on Time to
Pregnancy Among All Sub-Samples
HR (95% CI)

P-value

1.27 (0.78 - 2.06)

0.339

< 6 months

5.51 (2.09 - 12.00)

<0.001

>= 6 months

0.70 (0.19 - 2.38)

0.558

Entire Cohort (N=170)
No ART (N=82)

a

b

With ART (N=88)c
1.28 (0.67 - 2.47)
0.449
aadjusted for age, obesity, race, ovarian infertility diagnosis, ART cycles
badjusted for age, obesity, blood pressure, alcohol use, tubal infertility diagnosis, ovarian infertility
diagnosis
cadjusted for age, obesity, race, ART cycles
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Specific Aim 2 Results
2a: To determine the factors that best predict the probability of pregnancy.
Among all sub-samples, stepwise analysis was conducted with a P-value
<= 0.20 for entry into the model. Age and obesity were also included, regardless
of P-value, because of their established association with probability of
conception. Resulting final models retained all other variables with P-values <=
0.20.
In sub-samples #1 (N=170) and #2 (N=82), ln(AMH) was initially included
in model testing. However, due to missing values of ln(AMH), the resulting
models only contained 142 and 57 observations, respectively. In both models,
ln(AMH) was not retained. For this reason, a second model was produced that
excluded ln(AMH) from being tested in each sub-sample. The resulting final
models therefore contained a larger sample.
Among the entire cohort (N=170), the resulting final model included the
following variables: age, obesity, ovarian infertility diagnosis, PCOS, and history
of HPV (Table 13). Obese women had significantly reduced odds (61% lower) of
conceiving than women who were not obese. Older women also had 19% lower
odds of becoming pregnant than younger women, but not significantly. Women
with an ovarian infertility diagnosis, as well as women with a PCOS diagnosis,
had roughly 2 times the odds of conceiving than women who did not have
ovarian or PCOS diagnoses. However, these estimates were not statistically
significant. Similarly, women with a history of HPV had nonsignificantly 2 times
the odds of achieving a pregnancy. Estimates for the final predictive logistic
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regression model among sub-sample #1 are shown in Table 10. In this subsample, a woman who is older than 32 (X1=1) and obese (X2=1), without an
ovarian infertility diagnosis (X3=0), but who has PCOS (X4=1) and a history of
HPV (X5=1), would have 1.33 odds of pregnancy. A woman with these
characteristics would have a moderate likelihood of conceiving, with a 0.57
probability.
Table 10: Predictive Logistic Regression Model on
Conception for the Entire Cohort (N=170)
OR (95% CI)

P-value

Age

0.549
<32
>=32

1.00 (Referent)
0.81 (0.41 - 1.61)

Obese

0.007

1.00 (Referent)
No
0.38 (0.19 - 0.77)
Yes
Ovarian Infertility Diagnosis
1.00 (Referent)
No
2.12
(0.88 - 5.10)
Yes
PCOS Diagnosis
1.00 (Referent)
No
2.22 (0.91 - 5.34)
Yes
History of HPV
1.00 (Referent)
No
2.09 (0.79 - 5.40)
Yes

0.094

0.078

0.136

Among the women with no ART (N=82), sub-sample #2, the final model
included age, obesity, and a PCOS diagnosis (Table 13). Women who were
older, and women who were obese, had 33% and 65% reduced odds of
conception, respectively, than younger women and women who were not obese.
Conversely, women with PCOS had 3.4 times the odds of conception than those
without PCOS. None of these estimates, however, were significant. Estimates for
the final predictive logistic regression model among sub-sample #2 are shown in
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Table 11. A woman who is younger than 32 (X1=0) but is obese (X2=1) and has
PCOS (X3=1), would have 1.16 odds of pregnancy. Having these would result in
a woman having moderate likelihood of conceiving, with a 0.53 probability.
Table 11: Predictive Logistic Regression Model on
Conception for Women with No ART (N=82)
OR (95% CI)
P-value
Age

0.439
<32
>=32

1.00 (Referent)
0.67 ( 0.24 - 1.86)

Obese

0.059
No

1.00 (Referent)

Yes

0.35 (0.12 - 1.04)

PCOS Diagnosis

0.081

No

1.00 (Referent)

Yes

3.38 (0.86 - 13.30)

Among women who did receive ART (N=88), sub-sample #3, variables
retained in the final model were age, obesity, ln(AMH), ovarian infertility
diagnosis, and history of chlamydia (Table 13). Women with an ovarian infertility
diagnosis had 8.3 times the odds of conception than those without an ovarian
infertility diagnosis (P-value=0.01). Obese women had 55% lower odds of
achieving pregnancy than women were not obese. For every one-unit increase in
ln(AMH), the odds of pregnancy increased nonsignificantly by 41%. Those
women with a history of chlamydia had 69% lower odds of conceiving than those
women who did not have a history of chlamydia (P-value=0.06). Estimates for the
final predictive logistic regression model among sub-sample #3 are shown in
Table 12. A woman who is older than 32 years of age (X1=1), is not obese
(X2=0), has AMH levels of 0.9 ng/mL (X3= -0.11), has an ovarian infertility
diagnosis (X4=1), and no history of chlamydia (X5=0), would have 8.9 odds of
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pregnancy. This combination of characteristics would result in a woman have a
very high likelihood of pregnancy, with a 0.89 probability.
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Table 12: Predictive Logistic Regression Model on
Conception for Women with ART (N=88)
OR (95% CI)
Age

P-value
0.933

<32
>=32

1.00 (Referent)
1.05 (0.35 - 3.13)

No

1.00 (Referent)

Yes

0.45 (0.17 - 1.21)

Obese

0.113

ln(AMH)

1.41 (0.91 - 2.20)

Ovarian Infertility Diagnosis
No
1.00 (Referent)
Yes

0.128
0.012

8.28 (1.59 - 43.22)
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History of Chlamydia

0.06

No

1.00 (Referent)

Yes

0.31 (0.09 - 1.05)

Table 13: Final Predictive Logistic Regression Models for Probability of Pregnancy Among Each Sub-Sample
Log (odds of Pregnancy) = β0+ β1*Age + β2*Obesity + β3*Ovarian Diagnosis + β4*PCOS Diagnosis+ β5*History
Entire Cohort (N=170)
of HPV
Log (odds of Pregnancy) = β0+ β1*Age + β2*Obesity + β3*PCOS Diagnosis
No ART (N=82)
ART (N=88)

Log (odds of Pregnancy) = β0+ β1*Age + β2*Obesity + β3*ln(AMH) + β4*Ovarian Diagnosis+ β5*History of
Chlamydia

2b: To determine the factors that best predict the time to pregnancy.
Predictive Cox models were produced to determine the time to pregnancy
for each sub-sample. Variables included in each model were those that were
retained in the respective logistic regression models from Specific Aim 2a. In
sub-samples #1 and #3, the ART per cycle, the time-varying covariate, was also
included.
Upon testing the Proportional Hazards assumption in sub-sample #1
(N=170) via correlation between Schoenfeld residuals of variables and time,
history of HPV violated the Proportional Hazards assumption, with a correlation
P-value of 0.01. By examining the log-negative log curves, no other variables
violated the Proportional Hazard assumption. Therefore, an extended Cox model
was produced with history of HPV*time. Additionally, when producing the model
with ARTcycle*time included, this interaction term was significant. Therefore, the
time-varying ARTcycle variable violated the Proportional Hazards assumption,
and the final model was additionally stratified by ARTcycles. The resulting final
model is shown in Table 14. The only statistically significant finding was for
history of HPV, which was associated with increased likelihood of conception,
especially early during follow-up. Older women became pregnant 27% slower
than younger women. Similarly, obese women achieved pregnancy 30% slower
than non-obese women. Women with an ovarian infertility diagnosis conceived
29% faster than women who did not have an ovarian infertility diagnosis.
Similarly, women with PCOS became pregnant 11% faster than women without
PCOS. Early into follow-up, women with a history of HPV were conceiving faster
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than women without a history of HPV. At 3 months of follow-up, those with a
history of HPV were conceiving 2.5 times faster, significantly, than those without
a history of HPV. At 6 months, women with a history of HPV were becoming
pregnant 37% faster than those without HPV, but not significantly. At 9 months,
hazards are reversed, and those with a history of HPV start to become pregnant
slower than those without HPV, and even slower at 12 and 15 months. These
estimates, however, are not significant. In general, the effect of having a history
of HPV is inversely related to time; those with a history of HPV conceived faster
than those without a history of HPV early on, and as time progressed, they
conceived slower and slower than those without a history.
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Table 14: Predictive Cox Model of Conception
for the Entire Cohort (N=170) Stratified by ART
per Cycle
HR (95% CI)
P-value
0.177
Age
<32

1.00 (Referent)

>=32

0.73 (0.46 - 1.16)
0.136

Obese
No

1.00 (Referent)

Yes

0.70 (0.44 - 1.12)

Ovarian Infertility Diagnosis
No

1.00 (Referent)

Yes

1.29 (0.74 - 2.24)

0.364

0.680

PCOS
No

1.00 (Referent)

Yes

1.11 (0.68 - 1.82)
0.038

History of HPV
No

1.00 (Referent)

At 3 Months
At 6 Months

2.52 (1.15 - 5.56)
1.37 (0.85 - 2.22)

0.021
0.194

At 9 Months

0.75 (0.29 - 1.96)

0.555

At 12 Months

0.41 (0.08 - 2.12)

0.285

At 15 Months

0.22 (0.02 - 2.36)

0.212

Upon testing the Proportional Hazards assumption for variables included
in sub-sample #2 (N=82), no violations occurred. The final Cox model is shown in
Table 15. Among the women who never received ART, older women conceived
23% slower than younger women. Similarly, obese women conceived 52%
slower than women who were not obese. Women with PCOS achieved
pregnancy 2 times faster than women without PCOS. None of these estimates,
however, were significant.
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Table 15: Predictive Cox Model of Conception
for Women with No ART (N=82)
HR (95% CI)
Age

P-value
0.507

<32

1.00 (Referent)

>=32

0.77 (0.36 - 1.66)

Obese

0.091

No

1.00 (Referent)

Yes

0.48 (0.21 - 1.12)

PCOS

0.118

No

1.00 (Referent)

Yes

2.09 (0.83 - 5.28)

In sub-sample #3 (N=88), all initial variables included in modeling met the
Proportional Hazards assumption. When ARTcycle*time was included in the
model, the estimate was significant, and therefore violated the Proportional
Hazards assumption. The final Cox model was therefore stratified by ART per
cycle. The final Cox model for women who ever received ART is shown in Table
16. Among those women who ever received ART, age was not associated with
conception rate. Obese women achieved pregnancy 28% slower than women
who were not obese. For every one unit increase in ln(AMH), pregnancy
occurred 9% faster; conception occurred faster with increased AMH levels.
Those women with an ovarian infertility diagnosis were becoming pregnant 33%
faster than women without an ovarian infertility diagnosis. Lastly, women with a
history of chlamydia achieved pregnancy 16% slower than those without a history
of chlamydia. None of these estimates, however, were significant.
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Table 16: Predictive Cox Model for Women with ART
(N=88) Stratified by ART per Cycle
HR (95% CI)
Age

P-value
0.987

<32

1.00 (Referent)

>=32

1.01 (0.53 - 1.90)

No

1.00 (Referent)

Yes

0.72 (0.37 - 1.40)

Obese

0.334

ln(AMH)

1.09 (0.88 - 1.35)

Ovarian Infertility Diagnosis
No

1.00 (Referent)

Yes

1.33 (0.66 - 2.68)

History of Chlamydia

0.449
0.427

0.644

No

1.00 (Referent)

Yes

0.84 (0.39 - 1.78)
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F. DISCUSSION
This thesis identified predictors of successful conception and assessed
the effects of history of STI on the likelihood of conception among a cohort of
women seeking fertility counseling. Prior evidence suggests that certain STIs,
such as chlamydia and gonorrhea, can cause tubal factor infertility by means of
PID [11, 12, 85-88]. However, in no studies of conception among infertile couples
is STI a factor of conception. This study, to the best of our knowledge, is the first
to consider and explore the effect of history of STI on the likelihood of conception
among infertile women.
The findings of this study show that, among infertile women, history of STI
has a strong positive association with likelihood of pregnancy and less time to
achieve pregnancy. This finding is not consistent with previous literature claiming
that certain STIs can cause infertility [11, 12, 85-88]. However, in these
mechanisms, the STI goes untreated, and thereby causes PID and,
subsequently, tubal factor infertility. In the current population, none of the women
tested positive for a current STI, but rather reported having an STI in the past.
Hence, the assumption is made that the infertile women of this population who
have ever had an STI were able to treat the STI before PID and tubal damage
occurred. This is supported by the effect mediation analysis between tubal
infertility and the effect of STI on pregnancy in sub-sample #2; removing the
variable did not affect the OR of history of STI on conception. Additionally, an
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assumption can be made that women with a history of STI are more likely to
have higher frequencies of coital activity, thereby increasing their likelihood of
conception and resulting in becoming pregnant faster. However, intercourse
frequency was not collected from our participants, and therefore could not be
included in modeling. Future studies assessing how history of STI affects the
likelihood of pregnancy in infertile women should include a measure of coital
frequency. It should also be noted that the current study started with a population
that consisted of some women who were already infertile so the progression of
an STI could not be followed to determine a true causal relationship between STI
and its effects on conception.
Among sub-sample #1 (N=170), the logistic regression and survival
analysis are in agreement; the OR for history of STI are estimated in the same
direction as the HR for history of STI. The same is only true in sub-sample #2
(N=82) before 6 months, where both the odds and the hazards are greater in
those with a history of STI; after 6 months, those with a history of STI have lower
hazards. Likewise, among sub-sample #3, the OR and HR for history of STI
agree: history of STI increases the odds and the hazards of pregnancy.
This thesis also determined which factors predict pregnancy among a
cohort of women seeking fertility counseling. Previous studies among infertile
women have found that factors significantly associated with pregnancy were
secondary infertility [57, 59], shorter duration of infertility [9, 55, 57-59, 61],
younger female age [3, 4, 6, 8, 9, 56, 57, 59], younger male age [9], higher
sperm volume and sperm motility [5, 56], number of ART treatments [8], and
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infertility diagnoses [2, 3] including unexplained [3, 5, 7, 8, 57, 59], male factor
[57, 59], endometriosis [3, 57], tubal factor [2, 57], and ovarian factor [2, 7, 58]. In
this study, however, the only factors found to be significantly associated with
pregnancy were obesity (among sub-sample #1), which reduced probability of
conception, and ovarian infertility diagnosis (among sub-sample #3), which was
associated with greater likelihood of conception. Additionally, the only factor
found to be significantly associated with the time to conception among infertile
women was history of HPV (among sub-sample #1), which was associated with
faster time to conception.
Among sub-sample #1 (N=170), the logistic regression and survival
analysis are in agreement among all predictors. However, the OR and HR for
history of HPV only agree during the first 6 months, where those with a history of
HPV have increased odds and hazards of pregnancy; after 6 months, the
hazards are higher those without a history of HPV. In sub-sample #2 (N=82),
effect measures are in agreement; for each predictor, its respective OR and HR
are estimated in the same direction. Likewise, in sub-sample #3 (N=82), for all
predictors, effect measures are in agreement.
Interestingly, among those women who did receive ART, sub-sample #3
(N=88), women with an ovarian infertility diagnosis had 8 times the odds of
conceiving and conceived 33% faster than women without an ovarian infertility
diagnosis. The question remains as to why an ovarian infertility diagnosis
increases the odds of and decreases the time it takes to becoming pregnant. The
answer likely lies in the fact that most ovarian diagnoses can be overcome by
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either lifestyle changes, such as weight management, or ART, such as OI; or
when OI fails, IVF [46].
Additionally, among the women who never received ART, sub-sample #2
(N=82), those with PCOS had 3 times the odds of conceiving and conceived 2
times faster than those who did not have PCOS. Again, this is likely due to the
fact that PCOS can achievably be overcome, and, for certain cases, requires no
ART; obese women with PCOS can overcome their infertility with weight loss,
while nonobese women can overcome their infertility with OI hormone pills [46].
It is also interesting that among sub-sample #3 (N=88), those with a
history of chlamydia had nonsignificantly lower odds of conceiving on than those
without chlamydia; this may be due to chance or it may be that chlamydia has a
different anatomical impact than other STIs, such as increasing the likelihood of
PID.
In descriptive analyses among each sub-sample, lower blood pressure
was nonsignificantly associated with achieving pregnancy. It is possible that high
blood pressure is an indicator for poor underlying cardiovascular health.
Additionally, obesity, a known factor of infertility, is associated with hypertension
[97].

Spontaneous Conception Rates
In this cohort of 170 women receiving fertility counseling, there were a
total of 41 (24.1%) spontaneous pregnancies.
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Among the women who never received ART (N=82), there were 32
(39.0%) spontaneous pregnancies within a cumulative follow-up time of 484
months, for a rate of 6.61 pregnancies every 100 months. The 3-year risk for
spontaneous pregnancy would be calculated to be 90.7%. However, this is
assuming that fecundability of the population remains constant through time,
when in reality, fecundability decreases over time as the more fertile women are
removed from the sample. Other studies among untreated infertile women report
3-year spontaneous conception rates at 24.9% [59], 38.2% [57], and 72.0% [58].
The much larger probability of pregnancy reported here could be explained by
the fact that our sample likely has higher fecundability than other studies of
women seeking fertility treatment. For example, we did not require women to
meet any definition of infertility in order to be included in the study. In fact, of the
82 women who remained untreated by ART, 35 (42.6%) had an unknown
infertility diagnosis, which was not considered in other studies.
Among the women who did receive ART (N=88), 9 (10.2%) women
achieved a spontaneous pregnancy within a cumulative follow-up time of 483
months, for a rate of 1.8 spontaneous pregnancies every 100 months. With this
rate, a 5-year risk for spontaneous conception would be 66.0%, again making the
strong assumption of constant fecundability over time for all women who did
receive ART. One study reported a 5-year live-birth after spontaneous
conception rate of 18.1% [60]. Another study, however, reported a 5-year
spontaneous conception rate of 60.2% [9]. However, that study only included
women with an unexplained infertility diagnosis, whereas the current sub-sample
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consisted of 25 (28.4%) women with an unexplained infertility diagnosis.
Unexplained infertility is an infertility diagnosis related to the strongest likelihood
of pregnancy. These results are comparable to the current study’s report of
66.0%, as the population used in the current study is probably more fertile than
most other populations.

Strengths and Limitations
The LOUSSI Study is longitudinal and prospective in design. One strength
of the design is the ability to lower and potentially eliminate the amount of recall
bias from participants. Follow-up with participants occurred starting at 6 months
post-enrollment and will continue every 6 months. With short follow-up intervals,
there is a small likelihood of women forgetting their conception date or how long
they continued trying to conceive. Additionally, the study design allows the
collection of time and any wanted time varying covariates, making survival
analyses and Cox models possible to produce; therefore, measures of effect are
more accurate than without time data.
Another strength of the study is the retention rate. Of the original 264
participants, follow-up data was collected for 170 (64.4%). However, of the
participants that consented to being recontacted (n=157), follow-up data was
successfully collected 128 (81.5%) of them, with 42 (40.0%) additional follow-up
data via medical records for those who did not consent to being recontacted
(n=105).
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There are several limitations to the current study, with the most obvious
being the sample size. The small sample of 170 has the potential to create low
power and imprecise measures of effect, which is evident, as several of the
reported ORs and HRs have wide confidence intervals. Additionally, given the
small sample size, the reported estimates of effect measures by have been
totally left up to chance.
Selection and misclassification bias were likely present in this study. In the
recruitment phase of the study, physicians of the REI clinic were ‘gatekeepers’ of
the study and determined which of their patients they recommended participating
in the LOUSSI Study. This filter led to only a portion of eligible women being
invited to enroll into the study. Additionally, selection bias likely occurred in the
recontact phase, as women who had achieved a pregnancy were probably more
likely to be successfully recontacted. This bias would lead to elevated conception
rates being reported. In addition, the main predictor for specific aim 1 was history
of STI, which was a self-reported variable and likely suffered from some
misclassification. It is likely that some women who ever had a history of STI did
not report it, either intentionally or otherwise. Additionally, unless collected via
medical records, pregnancy data was also a self-reported variable. The potential
misclassification of these variables would result in inaccurate estimates of effect
measures.
Another limitation that should be noted is that the time data was collected
by months, and not by menstrual cycles. Some women have irregular
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menstruation, and cycle length varies from woman to woman; therefore using
follow-up time in months does not accurately reflect the number of cycles at risk.
In terms of fertility diagnoses, the cohort of women used for this study was
not comparable to other populations assessed in conception studies. Multiple
women in the LOUSSI Study were diagnosed with more than one infertility
diagnosis, with some having up to three diagnoses. In other studies, women
typically have one diagnosis; making it possible to determine effect estimates of
each diagnosis, relative to one other reference diagnosis. However, in this study,
effect estimates for diagnoses could only be determined by comparing those with
a specific diagnosis to those without the same diagnosis.
Additionally, most other studies assess very specific populations, whether
they be truly infertile, diagnosed with a certain infertility diagnosis, or by their
treatment methods. The women in the LOUSSI Study were relatively
heterogenous compared to other studies, in that some women had no infertility
diagnosis and in the women’s treatment methods could vary over time – whether
by type of treatment or by status of treatment. With this heterogeneity interpreting
effect estimates should be done cautiously; such varying data makes it difficult to
produce accurate effect estimates.

Suggestions for Further Research
In future efforts assessing how history of STI affects the likelihood or time
to conception, coital frequency should be collected, as the frequency of
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intercourse could be a key confounder in the relationship between history of STI
and achieving a pregnancy.
Additionally, future studies should make great efforts to collect time data
by menstruation cycles, and not in months, as some women do not have regular
periods. This can be accomplished by collecting daily urine samples and
measuring levels of reproductive hormones such as LH. Access to medical
records is also an imperative part of a fertility study; access to detailed records of
ART treatments, clearly defined diagnoses, and conception dates eliminate the
potential for misclassification and recall bias. Daily diaries can ideally be used to
record intercourse, menstruation and time-varying variables such as alcohol and
smoking.
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G. SUMMARY AND CONCLUSION

This thesis aimed to identify predictors of pregnancy and the effect of STI
history on probability of conception in a population of women seeking fertility
counseling. This population was not a homogeneously infertile population, and
24% conceived naturally during follow-up. Obesity, the type of infertility
diagnosis, and history of HPV were significant predictors of pregnancy in this
small study. History of STI was associated with higher odds of pregnancy and
shorter time to pregnancy, nonsignificantly however, regardless of ART
treatment. This may be due to confounding by coital frequency; future studies of
STI history and conception should make efforts to record intercourse frequency
in a prospective manner.
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